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DISSERTATION ABSTRACT 
 
Daniel Kevin Fowler  
 
Doctor of Philosophy 
 
Department of Biology 
 
December 2015 
 
Title: The SynCAM Family of Cell Adhesion Molecules Function Redundantly to Shape 
the Excitatory Synapse 
 
 
Functional characterization of synaptic proteins is often precluded by 
compensation not only among converging signaling pathways but also between 
structurally and functionally similar genes.  One such gene family, the synaptic cell 
adhesion molecules (SynCAMs), contains four nearly identical members of which 
SynCAM1-3 are highly localized to excitatory synapses.  SynCAMs have been 
demonstrated to have a clear synaptogenic potential when ectopically presented, either 
artificially or by overexpression, to developing neurons both in vitro and in vivo.  Despite 
these observations, conflicting reports from gain- and loss-of-function experiments 
prevent the development of a cohesive functional model for SynCAMs in excitatory 
synapse formation.  To overcome potential SynCAM functional redundancy and 
simultaneously compare effects of SynCAM knockdown and overexpression in cultured 
rat hippocampal neurons, I developed a tool for efficient multi-gene knockdown using 
artificial microRNAs.  I then applied this tool with a novel analysis method which I call 
Mosaic Expression with Differentially Localized Reporters (MEDLR).  Using MEDLR, I 
uncover novel synaptic phenotypes due to SynCAM1-3 knockdown which suggest 
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SynCAM1-3 function redundantly through postsynapse-specific mechanisms to regulate 
excitatory synapse number and size. 
This dissertation contains both published and unpublished co-authored material. 
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CHAPTER I 
INTRODUCTION 
 
Preface: SynCAMs in Synapse Development 
Correct nervous system function depends on the correct development of synapses, the 
points of contact and communication between neurons.  Synaptogenesis, the process of synapse 
formation, is thought to be initiated by physical contact of adhesion molecules located on a 
presynaptic axon and postsynaptic dendrite of two different neurons (for review see Garner et al., 
2002; Waites et al., 2005; Washbourne 2004). In addition to holding synapses together, 
interaction between adhesion molecules triggers the recruitment of distinct pre- and post-synaptic 
components.  For the entirety of this dissertation I will focus on excitatory synapses, which use 
the neurotransmitter glutamate, and represent the vast majority of synapses in the mammalian 
central nervous system (CNS) (Kandel, 2013). The human cerebral cortex, which contains 80% of 
brain mass but only about 20% of total brain neurons (Herculano-Houzel, 2009), has been 
proposed to contain on the order of 1014 synapses (100 trillion), a figure that is nearly 1000-fold 
higher than the estimated number of stars in the milky-way galaxy (Drachman, 2005).  
How does the brain make such a staggering number of neuronal connections, yet form 
them in a programmed manner which leads to a very set outcome? The process of excitatory 
synapse formation requires the recruitment of glutamate-filled synaptic vesicles to the presynaptic 
active zone as well as glutamate receptors and scaffolding molecules of the membrane-associated 
guanylate kinase (MAGUK) family to the postsynaptic density (PSD).  A large number of 
adhesion molecules are known to be important for synapse formation including 
neurexin/neuroligins, cadherins, neuronal cell adhesion molecule (NCAM), and Ephrin-EphR 
(ephrin receptor) complexes (Tallafuss et al., 2010).  For my dissertation, I have investigated an 
additional subset of synaptogenic adhesion molecules, the nectin-like synaptic cell adhesion 
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molecule (SynCAM) family.  Despite being linked to cognitive functions and disorders as well as 
clearly playing a role in synapse formation, the molecular mechanisms of SynCAM-mediated 
synaptogenesis are ill-defined.  Here, I begin with a brief review covering the current knowledge 
of SynCAM function in excitatory synapse development.  I conclude the introduction by outlining 
the open questions about SynCAM function that my doctoral research intended to answer and the 
general approaches I used in subsequent chapters to address them. 
 
The Nectin-like Synaptic Cell Adhesion Molecule (SynCAM) Family of Proteins 
In mammals, SynCAMs are a family of 4 proteins (SynCAM1-4) belonging to the 
immunoglobulin superfamily of cell adhesion molecules (IgCAMs) and are encoded by the cell 
adhesion molecule 1-4 (CADM1-4) genes (Biederer, 2006; Thomas et al., 2008).  Evolutionarily, 
SynCAMs are a fairly recent gene lineage since they are only found in vertebrates (Biederer, 
2006), in contrast to much older synaptogenic adhesion molecules such as neuroligins, which 
appeared concurrently with the evolution of the first synapses around one billion years ago, or 
compared to even older protosynaptic adhesion molecules including neurexins and NCAM (Ryan 
and Grant, 2009).  SynCAM1, by far the most studied family member, was identified nearly 
simultaneously in multiple tissue types and therefore is known by a number of different protein 
names including immunoglobulin subfamily member 4 (IGSF4) (Gomyo et al., 1999), 
spermatogenic immunoglobulin superfamily (SgIGSF) (Wakayama et al., 2001), and RA175 
(Urase et al., 2001). SynCAM1 was also initially discovered as a tumor suppressor gene and 
termed tumor suppressor in non-small cell lung cancer (TSLC1) (Kuramochi et al., 2001). 
SynCAMs 3 and 4 were subsequently identified as putative tumor suppressors and were termed 
TSLC1-like 1 and 2 (TSLL1 and 2), respectively (Fukuhara et al., 2001).  Finally, because of 
their similarities to nectins, another IgCAM subfamily, SynCAMs are also known as nectin-like 
(Necl) molecules with SynCAM1 known as Necl2, SynCAM2 as Necl3, SynCAM3 as Necl1, and 
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SynCAM4 as Necl4.  For the entirety of this dissertation, I refer to the genes as CADMs based on 
their Human Genome Organization (HUGO)-defined nomenclature, and call the protein products 
of the CADM genes SynCAMs because they were given this name following their discovery in 
the context of the nervous system (Biederer et al., 2002). 
Structurally, SynCAMs are a single transmembrane-spanning proteins divided into an 
extracellular domain containing three extracellular Ig binding domains and a small intracellular 
region containing two short protein interaction sequences: the FERM (F for protein 4.1, Ezrin, 
Radixin, Moesin) and PDZ (PSD-95, Dlg1, ZO-1) type II motifs (Biederer, 2006). The first Ig 
domain in the extracellular region was shown to be necessary for the trans-binding ability of 
SynCAMs (e.g. binding between pre- and postsynaptic SynCAMs) (Biederer et al., 2002).  All 
SynCAMs have been shown to engage in homophilic trans-interactions (Fogel et al., 2007). 
Additionally, SynCAM1 and 2, SynCAM2 and 4, as well as SynCAM3 and 4 have been 
demonstrated to form heterophilic trans-interactions (Fogel et al., 2007).  Such heterophilic 
binding is also known to be stronger than homophilic interactions (Fogel et al., 2007). The second 
and third Ig domains are known to be necessary for SynCAMs to form homo- and hetero-philic 
cis-interactions (e.g. clustering of SynCAMs in the same membrane), which potentiate their 
trans-binding ability (Fogel et al., 2011).  Interestingly, the second and third Ig domains can also 
form cis-interactions with other transmembrane proteins, including certain receptor tyrosine 
kinases (RTK), as a mechanism to modulate RTK signaling (Kawano et al., 2009; Kim et al., 
2011).  The SynCAM intracellular tail is the most conserved region, with identical PDZ motifs 
(c-terminal three-amino acid YFI sequence) and nearly identical FERM motifs (Biederer, 2006) 
across all four mammalian protein isoforms.  Both motifs have been demonstrated to bind a 
multitude of signaling and scaffolding molecules, and accordingly the intracellular region is an 
attractive candidate for signal-transducing abilities of SynCAMs (Frei and Stoeckli, 2014).   
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Genomic and Behavioral Associations Link SynCAMs to Cognitive Functions 
A number of genetic association studies strongly link SynCAMs to the occurrence of 
many cognitive functions and disorders. The first such disorders were certain inherited-forms of 
autism spectrum disorder (ASD) (Zhiling et al., 2008). A subsequent study also linked SynCAM2 
to the occurrence of ASD (Casey et al., 2012). Behavioral data in rodent models corroborated 
these findings because SynCAM1 knockout mice display social deficits commonly associated 
with autistic-like symptoms (Takayanagi et al., 2010), with aberrant accumulation of SynCAMs 
in endoplasmic reticulum (ER) and subsequent ER stress suggested as a cellular basis of the 
behavioral phenotypes (Fujita et al., 2010).  Further, SynCAM1 knockout mice have impaired 
ultrasonic vocalization, a method for mother-offspring communication, which supports a role of 
SynCAMs in ASD because impaired communication is a hallmark symptom of autism (Fujita et 
al., 2012). More recently, SynCAMs have been strongly linked to major depressive disorders in 
humans.  This includes being identified as markers for clinical depression (Benton et al., 2012), 
bipolar disorder (Redei et al., 2014), and risk of suicidality (Niculescu et al., 2015).  A better 
understanding of SynCAM function may prove useful to the treatment of these disorders. 
Considering a more general neurological function, SynCAMs are implicated in cognitive 
processes.  For instance, behavioral data from studies of SynCAM1 knockout mice showed 
impairment during metrics of learning and memory (Robbins et al., 2010).  A recent genomic 
association study has also linked altered expression of SynCAM2 to certain inherited aspects of 
“high-order” cognitive ability, including executive function and processing speed (Ibrahim-
Verbaas et al., 2015).  Remarkably, behavioral data substantiates this association because 
SynCAM1 knockout mice display behaviors which parallel symptoms of attention deficit 
hyperactivity disorder (ADHD), which is thought to arise from impaired executive functions 
(Sandau et al., 2012). Intriguingly, new data on synapse evolution supports a model in which 
SynCAMs function in high-order cognition.  In such a model, the appearance and rapid 
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duplication of new synaptic molecules, which include SynCAMs, is thought to underlie the rapid 
evolution of complex neurological circuits in vertebrates due to a massive increase in synaptic 
proteome complexity (Ryan and Grant, 2009). 
 
SynCAMs Are Sufficient to Induce Presynapse Formation 
SynCAM1, the first SynCAM identified in the context of the nervous system, was 
identified by the remarkable ability to induce presynaptic protein clustering (Biederer et al., 
2002).  Specifically, in vitro experiments demonstrated that SynCAMs recruited presynaptic 
proteins to sites of axonal adhesion when in contact with co-cultured cells expressing SynCAM1.  
Furthermore, these artificially-induced contact sites formed fully functional presynaptic terminals 
(Biederer et al., 2002; Hoy et al., 2009; Sara et al., 2005). SynCAM2 was also demonstrated to 
contain the same presynaptogenic potential (Fogel et al., 2007). Further reports showed the same 
ability to recruit presynaptic components when artificially-synthesized SynCAMs were presented 
from non-biological materials such as microspheres or coated culture vessel surfaces (Breillat et 
al., 2007; Czondor et al., 2013).  Intriguingly, this implies a presynaptic recruitment method 
whereby clustering of SynCAMs alone is sufficient to initiate all of the steps necessary for 
presynaptic formation.  Later studies showed that manipulation of SynCAM levels altered the 
frequency of miniature excitatory postsynaptic currents (EPSCs) in pyramidal cells, both in vitro 
and in vivo, further implying that SynCAMs are important in active zone development (Robbins 
et al., 2010; Sara et al., 2005). 
Mechanistically, by using overexpresssed dominant-negative forms of the proteins in 
cultured neurons, the ability of SynCAMs to recruit presynaptic components was shown to be 
mediated, at least in part, by the PDZ motif located in the intracellular region (Biederer et al., 
2002; Sara et al., 2005). The FERM motif has been shown to bind and activate focal adhesion 
kinase (FAK) signaling in axonal growth cones, but this signaling occurred prior to axo-dendritic 
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contact (Stagi et al., 2010).  Therefore, no clear molecular mechanism linking SynCAMs to the 
process of presynapse formation has yet been demonstrated.  
 
Conflicting Results Among and Between SynCAM Gain- and Loss-of-Function Studies 
Currently, the majority of data on SynCAM function stems from gain-of-function studies 
using overexpressed transgenic SynCAMs.  For example, overexpression of SynCAM1 in vivo in 
mice increased hippocampal excitatory synapse density (Robbins et al., 2010).  Results for 
SynCAM1 in vitro have been contradictory, however, because some reports show overexpression 
in cultured neurons increased synapse density (Cheadle and Biederer, 2012), while other reports, 
even from the same group, displayed no change (Burton et al., 2012; Fogel et al., 2007; Sara et 
al., 2005).  Despite some inconsistencies, the overall data support a function of SynCAMs in 
endogenous synaptogenesis.  Importantly, because observations suggest that SynCAMs influence 
synaptic density, this implies that SynCAM overexpression can initiate formation of postsynaptic, 
as well as presynaptic, structures. It is important to note, however, that overexpression analysis 
can only demonstrate that SynCAMs are sufficient for synapse formation.   
Are SynCAMs necessary for synapse formation?  To answer this question, loss-of-
function analysis must be performed, which typically occurs through reduction of protein levels 
(knockdown) or genetic deletion (knockout).  Currently there is a lack of such experiments for 
SynCAMs.  One study showed that SynCAM1 knockout in vivo caused a small, but significant, 
change in both pre- and post-synaptic density in the hippocampus, suggesting that SynCAM1 was 
necessary for formation of both sides of the synapse (Robbins et al., 2010).  Again, however, 
loss-of-function experiments in cultured neurons showed contradictory results because SynCAM1 
knockout neurons or RNAi-mediated SynCAM1 knockdown did not show a decrease in synapse 
density as measured by immunostaining for synaptic components (Burton et al., 2012; Cheadle 
and Biederer, 2012).  Therefore despite SynCAMs having a clear synaptogenic potential, the 
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molecular mechanisms that SynCAMs use to form synapses remain unclear, and there is a need to 
reconcile gain- and loss-of-function phenotypes in order to characterize synaptic functions of 
SynCAMs. 
 
SynCAMs Likely Function Through Different Mechanisms Pre- and Post-Synaptically 
A fundamental, but remarkable, feature of neurons is the intrinsic ability for these cells to 
form two polarized, functionally distinct structures: the axon and the dendrite. Within these 
cellular processes, each also exclusively forms pre- or post-synaptic structures, respectively.  One 
clear reason that unique structures are formed in axons or dendrites is due to the shuttling of 
specific pre- or post-synaptic proteins into these already polarized parts of the cell. Accordingly 
most synaptic adhesion molecules are predominantly pre- or post-synaptically localized.  It would 
be easy to assume this differentiation results in activation of structure-specific signaling 
complements which ultimately underlie the formation of such distinct cellular components.  
Therefore it has been quite surprising to find extremely similar molecular mechanisms which 
form pre-and post-synapses.  For example, many adhesion molecules, despite being exclusively 
pre- or post-synaptic contain similar binding motifs and interact with the same proteins 
(Scheiffele, 2003; Tallafuss et al., 2010).  Additionally, many of the same scaffolding molecules, 
predominantly from the membrane-associated guanylate kinase (MAGUK) family, are localized 
both pre-and post-synaptically and are heavily bound to different classes of adhesion molecules 
on both sides of the synapse (Dalva et al., 2007; Kim and Sheng, 2004).  Finally, molecular 
delivery mechanisms of synaptic components, such as adapter proteins for vesicular cargo 
delivery, are often identical both pre- and post-synaptically (Akhmanova and Hammer, 2010; 
Schlager and Hoogenraad, 2009).  Together, these results instead support the notion that 
synaptogenesis activates highly symmetrical processes on both sides of the synapse, but which 
end in the formation of highly specialized structures.  
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SynCAMs are unique in that they are among a small subset of synaptic adhesion 
molecules which form symmetrical, homophilic trans-binding interactions.  Considering the 
notion that pre- and post-synapse formation occur through similar mechanisms coupled with the 
results of SynCAM overexpression which showed that SynCAMs can boost overall synapse 
density, it is not difficult to image that SynCAMs tap into a general mechanism both pre- and 
post-synaptically to initiate synapse formation.  This notion immediately falls apart however, 
from the fact that postsynaptically-clustered SynCAMs fail to recruit any known postsynaptic 
component (Breillat et al., 2007; Czondor et al., 2013; Graf et al., 2004).  These results show 
unambiguously that unlike presynapses, SynCAMs are not sufficient to form postsynapses.  
While this does not rule out that clustering is also necessary postsynaptically, it shows that 
SynCAMs require some additional factor to initiate formation of the postsynapse.  It will be 
critical to determine the differences in signaling mechanisms for SynCAMs pre- and post-
synaptically.   
 
Project Overview: The Quest for a Cohesive Functional Model for SynCAMs 
Characterizing the molecular mechanisms of SynCAM-mediated synapse formation have 
proven problematic.  A possible reason for this difficulty is functional redundancy.  In many 
cases characterizing molecular functions at synapses is precluded not only by massive overlap in 
signaling pathways and binding partners (Dalva et al., 2007; Kim and Sheng, 2004; Scheiffele, 
2003), but also by functional redundancy within gene families themselves. Importantly, 
compensatory functions from additional family members or different adhesion molecules may 
hide crucial synaptic functions when manipulating individual genes. Indeed, redundancy has been 
observed for neurexins, neuroligins, calsyntenins, and MAGUKs, such that for each of these gene 
families protein reduction of at least three members is necessary to observe certain synaptic 
phenotypes (Gokce and Sudhof, 2013; Levy et al., 2015; Shipman et al., 2011; Um et al., 2014).  
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As mentioned above, SynCAMs are very structurally similar and most bind promiscuously to the 
same interacting molecules (Frei and Stoeckli, 2014). Combined with the observation that 
SynCAM1-3 have been found both pre- and post-synaptically at excitatory synapses (Fogel et al., 
2007), it is likely that SynCAMs, at least to some degree, share compensatory mechanisms during 
synapse formation. However, SynCAM functional redundancy has never been demonstrated.   
Are SynCAMs functionally redundant during synapse formation?  Furthermore, do they 
function differently during pre- and post-synapse formation?  I present in this thesis an attempt to 
tackle these questions.  Before I could address them, however, I needed to develop novel tools.  
To answer the first question, a method to generate loss-of-function of multiple SynCAM family 
members was essential.  Chapter II describes the development of an enhanced multi-gene 
knockdown method, which I applied for the efficient, simultaneous depletion of multiple 
SynCAM isoforms in a cultured rat hippocampal neuron system.  To answer the second question, 
I required a very robust, controlled assay to allow separation of pre- and post-synaptic effects.  
Chapter III describes the generation of a novel culture-based assay which allows discrimination 
of pre- and post-synaptic effects following the application of the knockdown tools presented in 
Chapter II.  Chapter III further explores the effect of SynCAM1-3 knockdown in this novel assay 
to determine if SynCAMs function redundantly, and if they differentially mediate pre- and post-
synapse development.   
This dissertation includes previously published and unpublished co-authored material.  
Chapter II contains material that was previously published in Nucleic Acids Research in 2015 
with co-authors Carly Williams, Alida T. Gerritsen, and Philip Washbourne.  Chapter III contains 
unpublished co-authored material with co-authors Carly Williams, Scott Stewart, Kryn 
Stankunas, and Philip Washbourne.   
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CHAPTER II 
IMPROVED KNOCKDOWN FROM ARTIFICIAL MICRORNAS IN AN 
ENHANCED MIR-155 BACKBONE: A DESIGNER’S GUIDE TO POTENT 
MULTI-TARGET RNAI 
 
This work was previously published in Nucleic Acids Research 
(doi:10.1093/nar/gkv1246) in November, 2015.  The work described in this chapter was co-
authored by myself, Carly Williams, Alida T. Gerritsen, and Philip Washbourne. Carly Williams 
helped run many of the experiments. Alida T. Gerritsen performed bioinformatic comparisons 
presented in Figure 2.  Philip Washbourne contributed to the experimental design and helped edit 
the manuscript.  I conceived the study and experimental design, ran the majority of the 
experiments, analyzed the data, and wrote the paper.  
 
INTRODUCTION 
The advent of molecular techniques based on RNA interference (RNAi) has opened many 
avenues to researchers for genetic manipulation (reviewed in ref. 1).  RNAi is a cellular pathway 
which uses short interfering RNAs (siRNAs) for posttranscriptional gene regulation mainly 
through the biogenesis and use of microRNAs (miRNAs) (for review see refs. 2-4).   Endogenous 
miRNAs are hairpin-like secondary structures found in many primary RNA transcripts (pri-
miRNAs).  In the nucleus, the microprocessor Drosha/DGCR8 complex binds and cleaves the 
basal stem of pri-miRNAs to liberate the stem-loop precursor miRNA (pre-miRNA). Pre-
miRNAs are then exported from the nucleus where the loop is cleaved by Dicer/TRBP to form a 
mature RNA duplex.  The guide strand, also known as targeting strand, is separated from the 
passenger strand and loaded onto an argonaute protein in the RNA induced silencing complex 
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(RISC), which then targets complementary mRNA transcripts for degradation or translational 
repression.       
Common methods for RNAi involve the use of vector-based expression of ~19-24 
nucleotide short hairpin RNAs (shRNAs) or synthetic targeting sequences embedded in 
endogenous miRNA backbones (artificial miRNAs, amiRNAs). Although functional backbones 
for amiRNA expression have been made from a number of naturally-occurring miRNAs (5-10), 
the two most commonly used amiRNA scaffolds are derived from either miR-30 or the synthetic 
inhibitory BIC/miR-155 RNA (SIBR) (11,12), especially since commercial vectors have been 
developed using these backbones (Open Biosystems Expression ArrestTM, GE Dharmacon and 
Block-iT Pol II miR RNAiTM, Life Technologies, respectively).  amiRNAs are embedded in 
sequences driven by RNA Polymerase II (Pol II) promoters, whereas shRNA expression is 
typically driven by constitutive Pol III promoters, such as H1 or U6. While there are conflicting 
reports, shRNAs generally outperform miRNAs for knockdown efficacy, likely due to higher 
shRNA expression levels using Pol III promoters (13-16). 
  Potent knockdown using shRNAs often comes at a cost, however, as at least three 
problems frequently arise from shRNA overexpression. First, high levels of shRNAs can cause 
toxicity due to oversaturation of the endogenous miRNA pathway (17-19).  Oversaturation may 
even result in lethality during in vivo studies (20).  amiRNAs are typically expressed at much 
lower levels and do not saturate endogenous RNAi pathways (13,21,22).  As such, amiRNAs are 
suitable for studies where shRNAs were toxic (23-25). Second, shRNA sequences are usually 
designed with perfectly-matched guide and passenger strands.  In contrast, amiRNAs are often 
designed with central mismatches between the guide and passenger strands, which may reduce 
off-target effects by decreasing unwanted passenger strand incorporation into RISC (26,27).  
Third, shRNAs often induce an immune response which may compound or mask RNAi-specific 
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effects (28-33).  Use of amiRNAs may circumvent this problem by avoiding immune activation 
(23,34). 
amiRNAs allow greater vector design flexibility and diversity of application compared to 
shRNAs.  For example, amiRNAs can be co-expressed with transgenes from a single cistron 
driven by Poll II promoters, such as cell-specific or conditional promoters (16,24,35-37).   
amiRNAs can also be placed in an intron so that miRNA processing does not interfere with 
transgene expression (11,38).  Indeed, it was originally shown that intronic SIBR amiRNAs are 
more potent than their exonic counterparts (11).  Further, amiRNAs can easily be chained in 
tandem, either to increase knockdown efficiency or to target multiple genes, without the need of 
dedicated promoters for each hairpin sequence (9,11,39,40).  Chained amiRNAs are particularly 
powerful tools for systems requiring multiple-target knockdown, such as studying functionally-
redundant genes.  For example, functional compensation often arises from gene duplications, 
which can mask phenotypes in single-knockout animals (41).  Targeted knockdown of multiple 
genes can be used to overcome functional redundancy, without the need for more difficult and 
laborious techniques such as conditional multi-gene knockout animals.  Furthermore, 
combinatorial amiRNA holds great promise for many gene therapies including those targeting 
rapidly-evolving pathogens (42,43) or human diseases caused by multiple factors, including 
cancer (44,45) 
Currently, many researchers choose to use shRNAs based solely on the potential for 
greater knockdown.  Because of the advantages afforded by miRNAs, enhanced knockdown 
rivalling that of shRNAs would be quite beneficial for many applications. Targeted optimization 
of miRNA scaffolds using insights gained from an improved understanding of miRNA function 
holds promise for increasing knockdown potency (26,46). For example, a recent deep-sequencing 
study uncovered conserved sequence elements of miRNA backbones that are associated with 
increased miRNA biogenesis and enhanced knockdown efficiency, including common UG and 
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CNNC motifs at the basal stem region (47).  Using this knowledge, an improved amiRNA 
backbone that enhanced microprocessor cleavage and knockdown potency, termed “miR-E”, was 
created by reintroduction of the wild-type CNNC motif into the commonly used miR-30 scaffold 
(46).   
Despite enormous advancement in algorithms and rules for designing functional RNAi 
sequences over the last decade, the process of screening for potent sequences is often time-
consuming, costly and laborious. In the present study, we suggest important criteria for effective 
amiRNA design. We also create and systematically test an enhanced SIBR (eSIBR) backbone 
containing exogenous UG and CNNC motifs at the basal stem which boosts relative amiRNA 
knockdown potency compared to the wild-type SIBR (wtSIBR) backbone.  We find chaining 
amiRNAs targeting different genes is itself sufficient to enhance knockdown of each individual 
gene, and that eSIBR outperforms wtSIBR for multi-gene knockdown in lentiviral-transduced 
primary cultured hippocampal neurons. Taken together, this study presents a template for 
developing and expressing amiRNAs for potent multi-target RNAi. 
 
MATERIAL AND METHODS 
Expression vectors and constructs 
GFP-SIBR vectors. EGFP coding sequence was inserted into HindIII and BamHI sites of 
pcDNA3 (Invitrogen) to make CMV-GFP.  The 150 nucleotide SIBR minimal region was 
amplified from Ui4-SIBR-GFP (11) and inserted between the EcoRI and XbaI sites of CMV-GFP 
to make CMV-GFP-SIBR using primers SIBR_f and SIBR_r. Ui4-SIBR-GFP was graciously 
provided by Dr. David Turner (University of Michigan).  To allow cloning of miRNA targeting 
sequences into the SIBR cassette using BbsI as previously described (11), the single native BbsI 
site in CMV-GFP-SIBR was silently mutated by site-directed mutagenesis (Agilent).  Site-
directed mutagenesis was used to introduce basal UG and CNNC motifs and to generate GFP-
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eSIBR (Figure 3A). The G at position -15 and +14 were also changed to U in order to maintain 
the proper predicted folded structure.  The CNNC motif was inserted beginning at position +19 
due to an unusual 2 nucleotide bulge at positons +2 and +3 in the predicted folded miR-155 
backbone.  The inserted position of the CNNC motif is therefore equivalent to the +17 position of 
miRNAs without a 3’ mismatch bulge.  To complete the CNNC motif, the C at position +18 was 
changed to U because it was shown that a C preceding the CNNC motif of miR-30 inhibited 
knockdown efficiency (46). The GFP-eSIBR vector has been deposited with Addgene 
(www.addgene.org). amiRNA sequences (Supplementary Table S1) were cloned into the SIBR 
cassette and chained as previously described (11). Scrambled control guide strand sequences used 
were scrambled1: 5’-AUUCUAAUACUACGUUCCGCAU-3’, scrambled2:  5’-
ACAACUUGUAUAUCGCGCAACU-3’ and scrambled3:  5’-
GAUCUUAUACUCGUGAUUGAGA-3’.  
Viral Vectors. The gateway cloning system (Invitrogen) was used to make viral vectors. To 
express miRNAs intronically, entry vector pME-SIBR was cloned by amplification of UI4-SIBR-
GFP immediately following the Ubiquitin C promoter and ending shortly after the final 
intron/exon boundary using primers Ui4_SIBR_attBf and Ui4_SIBR_attBf , then inserted into 
pDONR221. The pME-SIBR vector has been deposited with Addgene. Single or triplet SIBR 
cassettes were shuttled to pME-SIBR from GFP-SIBR using EcoRI and XhoI.  For entry vector 
p5E-CMV the CMV promoter sequence of pcDNA3 was cloned into pDONR221 P4-P1R using 
primers  CMV_attBf and CMV_attBr. For entry vector p3E-nlsGFP, nlsGFP was amplified from 
pME-nlsGFP (48) and inserted into pDONR221 P2R-P3 with primers nlsGFP_attBf and 
nlsGFP_attBr.  The viral vector LV-CMV-SIBR-nlsGFP was made using the above entry vectors 
in an LR reaction with a Gateway-compatible third generation lentiviral destination vector kindly 
provided by Dr. Kryn Stankunas (University of Oregon). 
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HA-Reporter vectors. Generation of HA-Cadm1 and HA-Neuroligin1 vectors were previously 
described (49,50).  To make HA-Cadm2 and HA-Cadm3 expression vectors, Cadm2 and Cadm3 
coding regions were amplified by PCR from mouse cDNA and inserted into pcDNA3 using 
primer pairs  Cadm2_f/r for Cadm2 and Cadm3_f/r for Cadm3.   HA tags were then inserted 
following the signal sequences with the megaprimer PCR technique using megaprimer HA-
Cadm2_mp for Cadm2 and HA-Cadm3_mp for Cadm3. HA-Neuroligin2, HA-Neuroligin3, HA-
Neurexin1, HA-Neurexin2, and HA-Neurexin3 vectors were kindly provided by Dr. Peter 
Scheiffele (University of Basel, Switzerland) and have been previously described (51-53). All 
primer sequences are listed in Supplementary Table S2 
 
amiRNA design 
amiRNA sequences were designed with considerations of previously described criteria for 
effective shRNA and miRNA sequences where possible (54-58).  Briefly, specific nucleotides 
included a U or A (preference for U) at guide position 1 relative to the 5’ microprocessor 
cleavage site, U/A preferences in positions 2-7, 10-14, and 17, and G/C preferences in positions 
19-21.  Another prominent consideration was to design sequences with an optimal G/C content 
between 36.4 to 45.5% when possible. Guide strands were also designed to be 2 nucleotides 
longer than the passenger strand as in the original report (11). Mismatches were positioned when 
possible to make three general structural categories: 1.) a “loop” mismatch where 3-5 adjacent 
nucleotides of the guide strand were not base paired to the target strand, 2.) a “3bp-spaced” 
mismatch where 2 single guide strand nucleotide mismatches were separated by 3 
guide/passenger base pairs and 3.) a “4bp-spaced” mismatch where 2 single guide strand 
nucleotide mismatches were separated by 4 guide/passenger base pairs.  Of our 129 amiRNA 
sequences, 9 did not fold into a secondary structure fitting the above categories and 6 amiRNA 
sequences were designed with two alternative mismatch structures (Supplementary Table S1).  
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For all amiRNA sequences, mismatches ranged between guide positions 11 and 17.  Predicted 
RNA secondary structures were generated using Mfold (59).  Schematics of miRNA secondary 
structures were drawn using VARNA (60). 
 
Mismatch structure and sequence-specific biases 
We determined the frequency (with a range of 0 to 1) of mismatch structures within our effective, 
ineffective, and total amiRNA sequences. For each structural class, we calculated effective and 
ineffective amiRNA structure bias as the deviation of the observed frequency from the expected 
frequency of the total amiRNA set.  Frequencies of nucleotides at specific guide strand positions 
were determined for our empirically-screened inefficient amiRNA sequences, and the combined 
efficient amiRNA set containing our screened efficient sequences and additional sequences 
obtained from primary literature (Supplementary Table S1).  Nucleotide frequencies were 
calculated using custom scripts built using the ShortRead package (61) in R (R Foundation for 
Statistical Computing, Vienna, Austria).  Nucleotide frequency biases were calculated as 
deviation of the observed nucleotide frequency at each position of the guide strand from an 
unbiased expectation of 0.25.  To remove the effect of design bias, we normalized the frequency 
bias of the effective amiRNAs by subtracting frequency biases for the ineffective amiRNAs.    
 
qRT-PCR 
First-strand cDNAs were synthesized from total RNA isolated following COS7 cell transfections 
using Superscript III reverse transcriptase (Invitrogen).  For experiments comparing pri-miRNA 
levels of target sequences in different SIBR backbones, cDNAs were created using oligodT 
primers for 50 minutes at 50°C.  For experiments comparing chaining-based effects, random 
hexamer primers were used with synthesis at 55°C for 1 hour.  In both cases, pri-miRNA levels 
were first normalized to gapdh levels as a loading control.  Rat gapdh primers were 
17 
 
qRat_gapdh_f/r. For experiments comparing pri-miRNA levels of target sequences in different 
SIBR backbones the primer pair qSIBR_f/r  flanking the 5’ and 3’ microprocessor cut sites in the 
SIBR backbones was used.  For experiments comparing chaining-based effects, primer qSIBR_f 
was used with hairpin–specific reverse primers for cadm1.1358 (qCadm1.1358_r) and nlgn2.1283 
(qNlgn2.1283_r).  qRT-PCR was performed using SYBR Green reagents (Kapa Biosystems) on a 
StepOnePlus Real-Time PCR System (Applied Biosystems).  Values and relative expression 
levels were compared using the ∆∆Ct method.  Primer sequences are listed in Supplementary 
Table S2.  
 
Lentiviral production and titration 
2.5x106 HEK293T cells were plated per 10-cm tissue culture dishes in 10ml of DMEM 
(Invitrogen), 10%FCS, 25 units/ml penicillin & 25 µg/ml streptomycin (Sigma).  ~24 h after 
plating, cells were transiently transfected using calcium-phosphate with 20 µg LV-CMV-SIBR-
nlsGFP vectors and packaging vectors (10 µg pMDL g/p RRE, 5 µg pRSV-Rev, 6 µg pVSV-G) 
(62).  6-8 h later media was replaced with 6ml/plate of fresh medium.  Medium was collected 48-
72 h after transfection and centrifuged at 3000xg for 5 min at RT.  Supernatant was passed 
through a 0.45 µm syringe filter and virus was concentrated by centrifugation on a 150,000 
MWCO column (Pierce).  20,000 HEK293T cells were plated per well of a 12-well plate and 
transduced with serial dilutions of concentrated lentivirus.  4-5 days after transduction, titres were 
calculated by flow cytometry on an Attune® acoustic focusing cytometer (Applied Biosystems) 
for GFP+ cells.  Infectious lentiviral particles/µl were calculated from viral dilutions where cells 
were transduced in the linear range (5-20% GFP+ cells). 
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COS7 cell culture and transfection 
COS7 cells (ATCC® Manassas, VA) were plated at a density of 50.000 cells per well of a 12-well 
tissue culture plate and maintained in DMEM (Invitrogen), 10%FCS, 25 units/ml penicillin & 25 
µg/ml streptomycin (Sigma).  ~24 h after plating, media was replaced with DMEM, 10% FCS 
without pen/strep and cells were transiently transfected with lipofectamine 2000 (Invitrogen) for 
~18 h, at which point media was replaced with DMEM, 10% FCS with pen/strep.  1 µg of 
reporter vector and 2 µg of GFP-SIBR vectors per well were co-transfected for knockdown 
experiments.  For transfections for harvesting total RNA for qPCR, 1 µg of GFP-SIBR vectors 
were transfected per well.  Cells were harvested 48-72 h following transfection.   
 
Primary hippocampal cell culture and viral transduction 
Hippocampal cultures were prepared from embryonic day 19 Sprague-Dawley rat pups as 
described (63), with minimal modifications.  100,000 cells were plated per well of a 12-well 
tissue culture plate coated with poly-L-lysine (Sigma, St. Luis, MO) in plating media (MEM 
(Invitrogen), 10% FCS, 20 mM dextrose, 25 units/ml penicillin and 25 µg/ml streptomycin) and 
incubated for 5-6 h.  Media was then changed to maintenance media (Neurobasal medium 
(Invitrogen), 1X B-27 supplement (Invitrogen), 0.5 mM Glutamax (Invitrogen), 50 units/ml 
penicillin, 50 µg/ml streptomycin, and 0.07% β-mercaptoethanol).  Half changes of maintenance 
media were performed every 3-4 days in culture.  200,000 infectious viral particles were added 
per well to transduce neurons at 2DIV.  Cells were harvested at 14DIV.  Studies were conducted 
in accordance with University of Oregon Institutional Animal Care and Use Committee protocols 
and in compliance with NIH guidelines for the care and use of vertebrate animals.   
 
 
 
19 
 
Quantitative western blotting 
Cells were harvested after a brief wash with 1X PBS using 2X Laemmli buffer (125 mM Tris pH 
6.8, 20% glycerol, 4% SDS, 0.004% bromophenol blue) with 5% beta-mercaptoethanol. Samples 
were heated at 95°C for 5 minutes, and proteins were separated by SDS-PAGE before transfer to 
a nitrocellulose membrane.  Membranes were blocked for 1h with 3% milk in PBS and treated 
with primary antibodies in 3% milk/PBS overnight at 4°C.  The next day membranes were 
washed 3 x 5 min with PBS, shaken with secondary antibody in 3% milk/PBS for 1 hr at RT, 
washed 3 x 5 min with PBS and imaged with an Odyssey-Fc quantitative western blot system (LI-
COR). Intensities were quantified per manufacturer’s instructions.  Primary antibodies used were 
actin (mouse, 1:2000, Millipore), HA.11 (mouse, 1:2000, Covance), GFP (chicken, 1:2000, Aves 
Labs), Cadm1 (chicken, 1:1000, MBL International), Cadm3 (rabbit, 1:1000, Sino Biological), 
and Pleio-Cadm (rabbit, 1:1000, Pierce).  Secondary antibodies used were anti-mouse and anti-
chicken IRDye 680RD, anti-rabbit and anti-chicken IRDye 800CW (donkey, 1:1000, LI-COR).  
Intensities were normalized to actin loading controls. Knockdown efficiency was calculated by 
setting levels relative to the empty GFP-wtSIBR controls for COS7 cell experiments or 
uninfected (no virus) controls for neuronal cultures.  Potency-of-knockdown was a metric with 
arbitrary units used to compare relative changes in knockdown efficacy between two conditions, 
and was calculated by dividing remaining reporter level (100% - knockdown efficiency) in a 
control condition (such as amiRNA in wtSIBR backbone or single amiRNA cassette) by the 
remaining reporter level in a comparison condition.  Potency-of-knockdown for the control 
condition was set to 1.   
 
Statistical analysis 
Where noted, p values obtained by statistical comparisons of two sample groups used Student’s 
two-tailed, unpaired t-tests and comparisons of more than two sample groups used one-way 
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ANOVAs followed by Tukey’s post-hoc pairwise comparisons.  For mismatch structure analysis, 
we performed Pearson’s χ2-tests (α=0.05) which compared observed versus expected number of 
effective amiRNA and ineffective amiRNAs for each mismatch class.  Expected effective and 
ineffective amiRNA numbers for each mismatch group were calculated using frequencies of the 
total amiRNA set.  For nucleotide frequency analysis at specific guide strand positions, we 
performed individual Pearson’s χ2-tests for actual counts (α=0.01) or normalized expectations 
(α=0.001) which compared A,U,G and C numbers at each guide strand position against an 
unbiased expectation of equal base frequencies. p values were adjusted using Šidák correction for 
inflated α levels due to multiple comparisons.   χ2-tests and t-tests were conducted in Microsoft 
Excel.  ANOVAs, Tukey’s post-hoc analysis, and Šidák corrections were performed in R.   
 
RESULTS 
Screening empirically-designed amiRNAs uncovers sequence-specific and structural 
features associated with efficient sequences 
To screen for effective amiRNA sequences, we used a vector with the Pol II 
cytomegalovirus (CMV) promoter driving expression of EGFP with the original 150bp wtSIBR 
cassette (11) in an exon immediately following the EGFP stop codon (GFP-wtSIBR, Figure1A 
and 1B). We tested a set of 22-nucleotide long amiRNA targeting sequences (total of 129, 
Supplementary Table S1) by inserting into the guide strand position of the wtSIBR backbone 
(Figure 1A).   amiRNAs targeted a total of nine genes spanning three neuronal cell adhesion 
protein families. Targeted genes were cadm1-3, nlgn1-3 and nrxn1-3 which code for the proteins 
Cell adhesion molecule (Cadm) 1-3, Neuroligin1-3 and Neurexin1-3, respectively.  As reporters 
for each targeted gene, we used Pol II-promoted hemagglutinin epitope-tagged constructs (HA-
reporter).  Using quantitative western blotting, we screened for effective amiRNA sequences co-
transfecting amiRNA-expressing vectors with their counterpart HA-reporter vectors in COS7  
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Figure 1. Overview of the wtSIBR cassette and amiRNA screening. (A) Nucleotide sequence of 
the 150-bp wtSIBR cassette from mouse and predicted miRNA secondary structure.  The guide 
and passenger strands are labelled green and yellow, respectively. Microprocessor cleavage sites 
are marked with closed arrows and the +1 and -1 nucleotides relative to cleavage are indicated. 
Dicer cleavage sites are marked with open arrows.  (B) Schematic representation of amiRNA 
screening.  COS7 cells were co-transfected with an HA-tagged reporter construct and an amiRNA 
cloned into the guide strand position of the wtSIBR backbone located in an exon following the 
GFP open reading frame (GFP-SIBR). amiRNAs are liberated by the microprocessor, exported 
from the nucleus where they are further processed and loaded into the RNA-induced silencing 
complex (RISC). Effective sequences lead to reduced reporter levels due to mRNA degradation 
or translational repression.  (C) Representative quantitative western blot using an HA antibody to 
measure reporter expression and (D) calculated reporter knockdown efficiency of cadm1 
amiRNAs. Knockdown percentage was calculated relative to reporter co-transfection with a 
vector containing an empty wtSIBR cassette (empty). Actin was used as a loading control.  
 
cells (Figure 1B). Cultures co-transfected with efficient amiRNA sequences showed decreased 
reporter expression compared to control cultures co-transfected with a GFP-wtSIBR vector 
lacking an amiRNA targeting sequence (empty) (Fig. 1C,D).  Sequences which resulted in >25% 
reporter knockdown were considered effective and all others were considered ineffective. 50 
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amiRNAs were effective and 79 were ineffective for reporter knockdown (Supplementary Table 
S1).  
Because SIBR-based amiRNAs are frequently designed with guide/passenger strand 
mismatches (11), we wanted to determine if mismatch structure was associated with knockdown 
efficiency. We grouped amiRNAs into three general categories that mimicked predicted 
naturally-occurring miR-155 secondary structures (Figure 2A).  We found that effective hairpins 
were less likely to contain a loop mismatch whereas ineffective hairpins were more likely to 
contain a loop mismatch (Figure 2B).  We also noted that effective hairpins tended to contain the 
3bp-spaced mismatch structure (p=0.07, Pearson’s χ2-test) and had little bias for or against the 
4bp-spaced mismatch structure.   The observed tendency for successful amiRNAs to contain the 
human mismatch structure may indicate a species-specific preference, because COS7 cells are a 
primate-derived line (African green monkey). Furthermore, G/C content of effective versus 
ineffective amiRNA sequences were compared and we found the G/C content of effective 
hairpins to be significantly less than ineffective hairpins (effective = 40.1% G/C, ineffective = 
43.5% G/C) (Figure 2C). 
Next, we examined the primary sequence factors that influenced knockdown efficiency. 
To do so, we mined primary literature to obtain an additional 133 effective SIBR amiRNA 
sequences to increase our comparison power.  We then calculated the nucleotide frequency bias at 
individual guide strand positions for the combined effective amiRNA set (n = 183) and our  
__________________ 
Figure 2 (next page).  Distinct structural features are associated with effective and ineffective 
amiRNA sequences. (A) Example miR-155 nucleotide sequences from different organisms and 
predicted secondary structures of distinct guide/passenger strand mismatches.  (B) Frequency bias 
of different mismatch structures found in effective and ineffective amiRNA sequences. Effective 
amiRNA n=50, ineffective amiRNA n=84, **p<0.01, Pearson’s χ2-test. (C) G/C nucleotide 
content of effective and ineffective amiRNA sequences. Effective amiRNA n = 50, ineffective 
amiRNA n=79, ***p<0.001 Student’s two-tailed t-test. Error bars represent s.e.m. (D) Nucleotide 
frequency bias of effective and ineffective amiRNA sequences and  (E) Normalized U/A or G/C 
nucleotide frequency bias of effective amiRNA sequences. Nucleotide positions are relative to the 
5’ microprocessor cleavage site. Effective amiRNA n =183, ineffective amiRNA n = 79, 
**p<0.01, ***p<0.001 Pearson’s χ2-test with Šidák correction for multiple comparisons. 
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ineffective amiRNAs (n = 79) (Figure 2D).  Note that we did not compare position 22 because 
many of the hairpins we obtained from the literature were cloned into a specific miR-155 
backbone (pcDNA
TM
6.2-GW/EmGFP-miR) where position 22 is always a G. As most amiRNAs 
are designed using common algorithms and guidelines, it was not surprising to find significant 
enrichments (α=0.01) of either U, A, or both at position 1, 2, 4, 7, 10, 12, and 14 in effective 
amiRNA sequences. We did note unexpected enrichment of G at position 8 and C at position 9.  
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Also as expected, both the effective and ineffective sequences displayed a G/C content 
asymmetry, with A/U-rich 5’ and G/C-rich 3’ ends.  This asymmetry has been shown to influence 
guide strand selection, is strongly associated with effective target sequences, and is a major 
criterion for effective siRNA design (64,65). Additionally, nucleotide frequencies at specific 
positions were quite similar in effective and ineffective sequences, likely indicating design bias 
for both sets. To eliminate design bias, we normalized the effective sequence nucleotide 
frequency by subtracting the values of the ineffective dataset.  Because our ineffective amiRNA 
set was smaller than the combined effective amiRNA set, we made our analysis more stringent 
(α=0.001).  Normalization removed all of the enrichments noted above except for position 10, 
where, strikingly, effective amiRNA sequences were likely to contain an A but not a U (Figure 
2E).  We did note a significant, but smaller, enrichment of A and depletion of U at positions 16 
and 17. We did not find any significant bias for G or C at any position (Figure 2E). Taken 
together, these results highlight important criteria for designing effective amiRNA sequences. 
 
Introduction of UG and CNNC motifs creates an enhanced SIBR (eSIBR) backbone 
Because recent studies have shown that targeted adjustments to the miR-30 backbone can 
increase knockdown efficiency (26,46), we tested whether modifications to the wtSIBR backbone 
could also increase amiRNA knockdown potency.  Auyeung and colleagues established that two 
key sequences at the basal stem in human miRNAs, the UG motif at positions -14 and -13 relative 
to the 5’ microprocessor cleavage site and the CNNC motif beginning between positions +16 and 
+18 relative to the 3’ microprocessor cleavage site, are associated with efficient miRNA 
processing and target knockdown (47). Neither of these motifs are present in the wtSIBR 
backbone, so we introduced the motifs singly or in combination to GFP-wtSIBR to create 
modified GFP-SIBR scaffolds (Figure 3A).   
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Figure 3.  The eSIBR backbone enhances knockdown potency.  (A) Nucleotide substitutions on 
and near the miR-155 basal stem which added the indicated UG and CNNC motifs to create the 
eSIBR backbone. Black circles indicate the wild-type sequence; blue circles are the modified 
sequence. Nucleotide numbers are relative to microprocessor cleavage sites. (B) Representative 
western blots and (C) quantification of reporter knockdown efficiency from data in 
Supplementary Figure S1 (see the Appendix) in COS7 cells co-transfected with the indicated 
amiRNAs in wild-type or modified SIBR backbones. Knockdown percentage was calculated 
relative to reporter co-transfections with a control vector containing an empty wtSIBR cassette 
(empty, not shown). Actin was used as a loading control. cadm1.715 and  nrxn1.1271 n = 4 
independent experiments, all others n = 3 independent experiments.  (D) Reporter knockdown 
efficiency as in (C) from single experiments with additional amiRNAs in the wtSIBR or eSIBR 
backbone. (E) Comparison of potency-of-knockdown between constructs containing amiRNAs in 
modified backbones (plotted points) relative to their counterparts in the wtSIBR backbone (dotted 
line).  If more than one experiment was conducted for an amiRNA, the average value is plotted. n 
= 16 amiRNAs, ***p<0.001, n.s. = not significant, one-way ANOVA with Tukey’s post-hoc 
comparison to the wtSIBR backbone group. For all graphs error bars represent s.e.m 
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We evaluated the effect of modified SIBR backbones on amiRNA knockdown efficiency 
for 16 of our effective amiRNA sequences (Figure 3B-D and Supplementary Figure S1; see the 
Appendix for supplementary figures).  The majority of these amiRNA sequences induced robust 
knockdown when expressed from the wtSIBR backbone (Figure 3C and 3D).  In order to be 
confident that our quantitative Western blot assay was suitable to measure further knockdown 
enhancement, we tested the precision of the assay for measuring small differences in protein 
levels.  We found that our assay was able to reliably and accurately measure differences as low as 
10% of HA-reporter protein levels (Supplementary Figure S2).  These results demonstrate that 
our quantitative Western blot assay is well suited to monitor differences in knockdown 
efficiencies due to backbone modifications.  
We performed 3-4 replicate experiments comparing knockdown efficiencies for five of 
our potent (>70% knockdown) amiRNA sequences expressed from the wtSIBR or modified 
backbones (Figure 3B and 3C, Supplementary Figure S1).  Changes in knockdown efficacy in 
response to introduction of single UG or CNNC motifs varied considerably for individual 
amiRNA sequences (Figure 3C).  In contrast, introduction of both UG and CNNC motifs into the 
SIBR backbone enhanced reporter knockdown for all 16 amiRNA sequences tested (Figure 3C 
and 3D). We named this backbone containing both motifs the enhanced SIBR (eSIBR) scaffold.  
Because the range of reporter knockdown from amiRNAs in the wtSIBR backbone was large 
(~25% to >90%, Figure 3C and 3D) and were difficult to compare directly, we used a relative 
metric that is independent of absolute knockdown percentage.  This metric, which we call 
potency-of-knockdown, is the inverse of the amount of the remaining reporter level compared to 
a control condition; an amiRNA that reduced the remaining protein to 1/2 of the control amount 
had a 2-fold potency-of-knockdown, one that reduced remaining reporter to 1/3 had a 3-fold 
potency of knockdown.. We used this metric to compare knockdown efficacy of amiRNA 
sequences in modified backbones relative to corresponding wtSIBR amiRNAs. The eSIBR 
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backbone reproducibly boosted potency-of-knockdown an average of ~2-fold over counterpart 
sequences in the wtSIBR backbone (Figure 3E).  
 
The eSIBR backbone enhances cleavage by the microprocessor 
To examine whether improved knockdown from the eSIBR backbone may be due to an 
increase in miRNA biogenesis, we used a previously established method for monitoring 
microprocessor cleavage (46). Because the amiRNA sequence is located in an exon following the 
GFP coding region, cleavage of the hairpin by the microprocessor separates the coding region 
from the polyA tail, which prevents nuclear export and destabilizes the mRNA, resulting in 
lowered GFP translation (Figure 4A).  Thus, lowered GFP levels indicate enhanced 
microprocessor cleavage.    
We used quantitative western blotting to measure GFP levels in COS7 cells transfected 
with GFP-SIBR vectors containing amiRNAs in the wtSIBR or modified SIBR backbones 
(Figure 4B).  We compared GFP levels in cells transfected with amiRNAs in modified SIBR 
backbones relative to their wtSIBR counterparts and found decreased GFP levels in cultures 
expressing eSIBR amiRNAs, but not in cultures with amiRNAs in backbones containing  
__________________ 
Figure 4 (next page).  The eSIBR backbone increases cleavage by the microprocessor.  (A) 
Schematic of microprocessor activity assay.  GFP-SIBR mRNA is either exported from the 
nucleus to be translated or the amiRNA is cleaved by the microprocessor and the mRNA is 
degraded.  (B) Representative western blots showing GFP levels in COS7 cells transfected with 
GFP-SIBR constructs containing the indicated amiRNAs in wild-type or modified SIBR 
backbones.  Actin was used as a loading control. (C) Comparison of GFP levels measured by 
quantitative western blot of COS7 cells transfected with GFP-SIBR constructs carrying amiRNAs 
in modified backbones (bars) relative to their corresponding wtSIBR counterparts (dotted line). 
(D) Representative SIBR pri-miRNA and gapdh loading control qRT-PCR amplification plots 
using cDNAs synthesized from COS7 cell total RNA following transfection of hairpin 
nlgn3.1900 in wtSIBR or modified backbones. Insets are of the threshold cycle region of the 
amplification curves. (E) Comparison of SIBR pri-miRNA levels measured by qRT-PCR of 
COS7 cells transfected with GFP-SIBR constructs carrying amiRNAs in modified backbones 
(bars) relative to their corresponding wtSIBR counterparts (dotted line).  If more than one 
experiment was conducted for an amiRNA sequence, the average value was used.  (C) n = 16 
amiRNAs, (E) n = 18 amiRNAs, **p<0.01, ***p<0.001, n.s.=not significant, one-way ANOVA 
with Tukey’s post-hoc comparison to the wtSIBR group.    Error bars represent s.e.m. 
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individual UG or CNNC motifs (Figure 4C).  This observation suggests that increased 
knockdown gained from the eSIBR backbone stems from enhanced microprocessor cleavage.   
To directly monitor amiRNA processing, we performed quantitative real-time PCR (qRT-
PCR) to measure unprocessed pri-miRNA levels in COS7 cells transfected with GFP-SIBR 
vectors and compared relative pri-miRNA levels of amiRNAs expressed from the modified SIBR 
backbones to pri-miRNA levels of their counterparts in the wtSIBR backbone. Mirroring the 
results obtained by monitoring relative GFP levels, only amiRNAs expressed from the eSIBR 
backbone, and not backbones with a single motif, showed significantly reduced pri-miRNA levels 
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of ~30% (Figures 4D and 4E).  Because these were overexpression experiments, the observed 
~30% reduction in pri-miRNA levels due to the eSIBR modifications is not representative of 
single-copy kinetics and likely under-represents the increase in the amount of pre-miRNAs able 
to enter the RNAi pathway.  Together, these results provide strong evidence that the eSIBR 
backbone enhances knockdown through increased microprocessor cleavage and liberation of pre-
miRNA hairpins.   
 
Chaining amiRNAs targeting different genes increases knockdown potency 
One useful feature of the SIBR cassette is the ability to easily chain amiRNAs in tandem 
(11). To simultaneously knockdown multiple genes, we chained together amiRNA triplets in the 
wtSIBR or eSIBR backbones, targeting three different cadm family or nlgn family genes (e.g. 
cadm1, 2 and 3 or nlgn1, 2 and 3) (Figure 5A).  Three unique scrambled amiRNA sequences 
targeting no known genes served as a control (scrambled1, 2 and 3).  
We wanted to determine if chaining amiRNAs in tandem influenced their individual 
efficacies.  Because DNA sequences can be highly homologous between gene family members, 
we investigated potential cross-targeting of amiRNA sequences within their gene family.  We 
monitored knockdown of HA-reporters when co-transfected with single amiRNAs against each of 
the family members (Figure 5B). We found that only one amiRNA, nlgn2.1283, not only reduced 
HA-Neuroligin2 levels but also HA-Neuroligin3 levels, presumably due to 19/22 nucleotide 
homology with the target sequence.  We therefore omitted HA-Neuroligin3 from subsequent 
analysis of linkage-based effects.  
To test if multimerizing amiRNAs could alter their efficiency, we used quantitative 
western blotting to monitor reporter knockdown in COS7 cells co-transfected with triplet 
amiRNAs and their corresponding HA-reporter vectors (Figure 5C). Knockdown efficiency was 
measured by normalizing reporter levels to control cultures co-transfected with an empty GFP-
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wtSIBR vector. Again in all cases, we found that single amiRNAs in the eSIBR backbone 
enhanced knockdown efficiency compared to single amiRNAs in the wtSIBR backbone and 
increased potency-of-knockdown ~2-fold (data not shown). Surprisingly, we found that 
concatenation of amiRNAs in the wtSIBR backbone targeting different genes was itself sufficient 
to increase knockdown efficiency for 4 of the 5 reporter constructs (Figure 5D).  To compare 
relative effects of chaining amiRNAs across different amiRNA sequences, we calculated potency-
of-knockdown for amiRNA triplets in the wtSIBR backbone compared to their corresponding 
single wtSIBR amiRNAs.  We found that chaining wtSIBR amiRNAs significantly increased  
potency-of-knockdown nearly 2-fold (~1.9-fold, Figure 5E). When compared to their single  
eSIBR amiRNA counterparts, triple amiRNAs also increased potency-of-knockdown ~1.9-fold  
__________________ 
Figure 5 (next page).  Chaining amiRNAs targeting distinct genes increases knockdown potency.  
(A) Schematic of GFP-SIBR constructs expressing a single hairpin or triple hairpins used in this 
figure. Single hairpin constructs contain an amiRNA targeting a single gene. Triple hairpin 
constructs contain three unique amiRNA sequences targeting different genes of the same family 
(e.g. cadm1, 2, and 3 or nlgn1, 2 and 3) or contain three unique scrambled sequences 
(scrambled1, 2, and 3).  (B) Representative western blots showing knockdown fidelity for all 
combinations of HA-reporter constructs co-transfected with single wtSIBR amiRNAs and a 
control vector containing an empty wtSIBR cassette (empty) in COS7 cells. Cross-targeting is 
marked by an asterisk. (C) Representative western blots and (D) quantification of reporter 
knockdown efficiency in COS7 cells co-transfected with GFP-SIBR constructs carrying indicated 
single or triple amiRNA sequences in either wtSIBR or eSIBR backbones.  Knockdown 
percentage was calculated relative to reporter co-transfections with a control vector containing an 
empty wtSIBR cassette (not shown).  Data for single eSIBR amiRNAs are not shown. Actin was 
used as a loading control. Values represent the average of 3 independent experiments. (E) 
Comparison of potency-of-knockdown for triple-amiRNA expressing constructs (bars) relative to 
their counterparts with single-amiRNAs in the wtSIBR backbone (dotted line) and (F) 
comparison of potency-of-knockdown for triple eSIBR amiRNA expressing constructs (bar) 
relative to counterparts single amiRNAs in the eSIBR backbone from experiments in (D).  Values 
represent the average of all values for 3 independent experiments of the 5 conditions as in (D) 
(total n=18 per group).  **p<0.01, ***p<0.001, student’s two-tailed t-tests against the relative 
control group (dotted line). (G) Comparison of potency-of-knockdown for triple-amiRNA 
constructs in eSIBR backbones (blue bars) relative to their counterparts expressing triple-
amiRNAs in the wtSIBR backbone (black bars) from data in (D).  n = 3 independent experiments, 
*p<0.05, **p<0.01, ***p<0.001, Student’s two-tailed t-test.  (H) Comparison of pri-miRNA 
levels measured by qRT-PCR in COS7 cells following transfection of single and triple 
cadm1.1358- and nlgn2.1283-containing SIBR constructs in either the wtSIBR or eSIBR 
backbones.  pri-miRNA levels are relative to the single wtSIBR amiRNA condition.  n = 3 
independent experiments, *p<0.05, **p<0.01, ***p<0.001, Student’s two-tailed t-test against the 
single wtSIBR amiRNA condition.  For all graphs, error bars represent s.e.m. 
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(Figure 5F), which suggests that the eSIBR backbone modifications do not interfere with 
chaining-based knockdown enhancement. As each amiRNA targeted distinct genes and enhanced 
knockdown was still observed, our results suggest a cooperative effect for miRNA biogenesis 
when amiRNAs are chained in close proximity.   
 
The eSIBR backbone enhances multi-gene knockdown 
To test if eSIBR amiRNAs retain their enhanced knockdown potential when 
concatenated, we calculated potency-of-knockdown for triplet GFP-SIBR constructs containing 
amiRNAs in the eSIBR backbone relative to corresponding single or triple amiRNAs in the 
wtSIBR backbone.   When compared to their triplet wtSIBR counterparts, triplet eSIBR 
amiRNAs increased potency-of-knockdown in all 5 conditions, with an average enhancement of 
~1.5-fold (Figure 5G), which is less than the expected 2-fold increase seen in single amiRNAs.  
When directly compared to their single amiRNA counterparts in the wtSIBR backbone, triplet 
eSIBR amiRNAs showed a nearly 3-fold increase in potency-of-knockdown (~2.9-fold, Figure 
5E), which is less than the expected ~4-fold enhancement in potency-of-knockdown if both the 
enhancement from the eSIBR backbone and the linkage-based increase were independently 
additive.  These two observations suggest that knockdown enhancement afforded by the eSIBR 
modifications is reduced when amiRNAs are multimerized.   Nevertheless, these results show that 
chaining eSIBR amiRNAs, even when targeting distinct genes, can further boost overall 
knockdown potency.    
 
Chaining-based knockdown enhancement is due to increased pri-miRNA processing 
We tested if the linkage-based increase in knockdown potency due to chaining amiRNAs 
in tandem was also due to enhancement in microprocessor cleavage of the pri-miRNA hairpin. In 
order to directly compare pri-miRNA processing between single and chained amiRNAs, we 
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designed primers to monitor the 5’-most hairpin for both the cadm1-3 and nlgn1-3 triple 
constructs (cadm1.1358 and nlgn2.1283, respectively) and used qRT-PCR to measure pri-miRNA 
levels in COS7 cells transfected with triple amiRNAs in the wtSIBR or eSIBR backbones as well 
as the corresponding single amiRNAs in the wtSIBR or eSIBR backbones. We again observed a 
significant increase in pri-miRNA processing from single eSIBR amiRNAs compared to their 
wtSIBR counterparts (Figure 5H). Chaining amiRNAs decreased pri-miRNA levels for both 
amiRNAs, although levels were reduced much more for nlgn2.1283 than for cadm1.1358 (92% 
and 30% reduction, respectively, Figure 5H).  For both amiRNAs, triple eSIBR constructs 
showed a further, but more modest decrease in pri-miRNA levels compared to triple wtSIBR 
counterparts (Figure 5H).  These results imply that knockdown enhancement due to chaining 
amiRNAs is from increased microprocessor cleavage.  
 
eSIBR boosts endogenous multi-gene knockdown potency 
Next, we tested the applicability of eSIBR amiRNAs for multi-gene knockdown of 
endogenous proteins.  We generated a lentiviral vector carrying triplet amiRNAs in the wtSIBR 
or eSIBR backbones which target cadm1, 2, and 3.  amiRNA expression is driven by the CMV 
promoter and located in an intron preceding the coding region for nuclear-localized GFP 
(nlsGFP) (Figure 6A).  We placed amiRNAs in an intron because intronic expression of 
amiRNAs enhances target knockdown (11). We transduced cultures of rat hippocampal neurons 
two days after plating (days in vitro, DIV) with high-titre lentivirus carrying triplet cadm 
amiRNAs or control triplet scrambled amiRNAs.  We then used quantitative western blotting to 
monitor endogenous Cadm protein knockdown in 14DIV cultures (Figure 6B).  We measured 
protein levels with antibodies against endogenous Cadm1, Cadm3 or pleio-Cadm, which 
recognizes Cadms 1, 2 and 3 (66), and measured knockdown efficiency by normalizing values to 
non-infected sister cultures (no virus) (Figure 6C).   For all antibodies tested, amiRNAs in the  
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Figure 6.  eSIBR enhances multi-target 
knockdown potency in primary neuron 
cultures.  (A) Schematic of lentiviral 
vectors used for multiple endogenous 
gene knockdown.  The cytomegalovirus 
promoter (CMV, yellow) promotes 
antisense-strand expression (relative to 
viral RNA) of amiRNAs located in an 
intron preceding a nuclear-localized 
GFP (nlsGFP, green) coding sequence. 
amiRNA triplets target cadm1, 2, and 3 
or contain three unique scrambled 
sequences (scrambled1, 2, and 3). 
Orange boxes represent viral-specific 
sequences. LTR, long-terminal repeat, 
RRE, Rev-response element, cPPT, 
central polypurine tract, WPRE, 
woodchuck hepatitis virus 
posttranscriptional regulatory element, 
SA, splice acceptor, SD, splice donor. 
(B) Representative western blots and 
(C) quantification of endogenous Cadm 
family knockdown efficiency in 14DIV 
cultured rat hippocampal neurons 
transduced with viral constructs 
carrying the indicated amiRNA 
sequences in wtSIBR or eSIBR 
backbones. Antibodies were against 
Cadm1, Cadm3 or Cadm1-3 (pleio-
Cadm).  Knockdown percentage was 
calculated relative to uninfected control 
cultures (no virus). Actin was used as a 
loading control. (D) Comparison of 
endogenous Cadm potency-of-
knockdown for viral vectors containing 
amiRNAs in eSIBR backbones (blue 
bars) relative to their counterparts in the 
wtSIBR backbone (black bars).  (C) and 
(D) n = 4 independent experiments, 
*p<0.05, **p<0.01, ***p<0.001, 
Student’s two-tailed t-test.  Error bars 
represent s.e.m. 
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eSIBR backbone significantly enhanced knockdown efficiency (Figure 6C).  We calculated 
potency-of-knockdown between triplet wtSIBR and eSIBR amiRNAs, and we found that the 
eSIBR backbone increased potency-of-knockdown an average ~2-fold over wtSIBR amiRNAs 
(Figure 6D).  These results show that eSIBR is more efficient than currently-used SIBR-based 
vectors for endogenous multi-gene knockdown.   
 
DISCUSSION 
The use of amiRNAs have been shown throughout a diverse range of experimental 
contexts as an efficient means for RNAi.  Despite the enormous benefits associated with 
amiRNAs, experimental application often suffers from insufficient target knockdown compared 
to other RNAi-based methods.  We showed here that targeted optimization of the amiRNA SIBR 
backbone, termed the eSIBR scaffold, greatly enhanced the relative knockdown potency of all 
amiRNA sequences tested. This potent effect was due to an increase in microprocessor cleavage.  
When we chained eSIBR amiRNAs, even when each amiRNA targeted a unique gene, potency-
of-knockdown was often enhanced more than 3-fold compared to single wtSIBR amiRNAs.  
Therefore, the eSIBR backbone offers great potential to boost amiRNA knockdown efficacy to 
comparable levels with methods such as shRNA without caveats routinely encountered with other 
RNAi-based techniques.  
 Using a large empirically-designed set of amiRNAs, we found specific sequences 
associated with efficient amiRNA sequences. We observed that effective sequences are highly 
biased for an A but against a U at guide position 10. Enrichment of A at position 10 has been 
previously noted for efficient shRNA and miR-30-based amiRNA sequences (55,57,67,68). 
Argonaute proteins in RISC cleave target mRNA between nucleotides complementary to guide 
strand positions 10 and 11.  Bias for A at guide position 10 in effective sequences may arise from 
increased mRNA cleavage efficiency because a U in the mRNA complementary to guide position 
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10 is the preferred substrate (57).  However, most previous studies also noted an enrichment of U 
at position 10 as well (57,67,68). In particular, studies which screened for effective amiRNA 
sequences using the miR-30 backbone found enrichment for both A and U at position 10 (55,69), 
suggesting that a bias against U at position 10 may be specific for SIBR amiRNAs. Taken 
together, these conflicting observations posit that differences between amiRNA expression 
systems, such as the loop sequence or inclusion of central mismatches, may alter primary 
sequences important for RNAi efficacy. Thus, our results highlight the need for more context-
dependent criteria for amiRNA design. 
We also observed structural criteria associated with effective amiRNAs.  We and others 
have found that G/C content of <50% is associated with effective sequences (57,70). Specifically, 
our experimental average of ~40% G/C for effective amiRNAs fell precisely at the median G/C 
range of effective sequences in a recent, high-throughput amiRNA screen (55). We also 
investigated the effect of guide/passenger mismatch structure on amiRNA efficiency.  We found 
that effective hairpins were not likely to contain an open loop mismatch and favored two 
mismatches separated by 3-basepaired nucleotides. We note that because COS7 cells are a 
monkey-derived line, the observed preference for the human mismatch structure may be due to 
specificities in miRNA processing machinery between species.  Whether mismatch structure 
preference is different for SIBR-based amiRNAs in different organisms will require further 
investigation.  Nonetheless, one should consider empirically optimizing mismatch structure when 
designing amiRNAs for this system if using different species. Previous studies have seen that 
introduction of central mismatches between the guide and passenger strands can improve 
knockdown efficacy in certain sequences (27,71), but to our knowledge this is the first report to 
systematically test preferred guide/passenger mismatch structures for an amiRNA system.  
Central mismatches can influence guide strand selection (72-74) as well alter loading onto 
functionally-distinct Ago proteins in RISC. For example, siRNAs containing central mismatches 
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shifts loading of guide strands from Ago2 to Ago1 in Drosophila, which alters target knockdown 
efficiency (75-77).  
Thus, in addition to general considerations for effective RNAi design, our results suggest 
two important criteria for the design of effective SIBR-based amiRNAs: (1) inclusion of A and 
exclusion of U at guide position 10, and (2) optimization of guide/passenger mismatch structure. 
 One interesting trend that we noticed when comparing modified backbones containing 
either single UG and CNNC motifs and the eSIBR backbone, which contains both, is that while 
both motifs generally enhanced knockdown efficiency, the effect of single motifs on the potency 
of individual amiRNA sequences varied considerably. In stark contrast, combining both motifs in 
the eSIBR backbone reproducibly enhanced potency-of-knockdown for all 16 amiRNA sequences 
~2-fold over identical sequences in the wtSIBR backbone.  Because the eSIBR backbone caused 
such a reproducible increase in knockdown efficacy, but the effect of the individual motifs did not 
appear to be additive, suggests the UG and CNNC motifs are functionally linked.   Indeed, we 
only observed increased cleavage by the microprocessor when both motifs were combined, as 
monitored either indirectly by GFP expression or directly by assaying pri-miRNA levels. 
Enhanced knockdown in the miR-30-based “miR-E” backbone by Fellmann and colleagues, 
which was created by reintroducing the wild-type CNNC motif, may support this notion because 
miR-30 already contained the basal UG motif (46).  The CNNC motif was originally shown to 
bind the splicing factor SRp20, and more recently the DEAD-box protein DDX17, both of which 
associate with and can regulate microprocessor activity, although specific modes of action are not 
known (47,78,79).  Further work will need to determine whether these regulatory mechanisms 
also involve the UG motif.  
 Our work strongly supports increased pri-miRNA processing as the causative factor of 
enhanced knockdown afforded by both amiRNA chaining and the eSIBR backbone 
modifications.  Both chaining and the eSIBR backbone decreased pri-miRNA levels, as 
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monitored by qRT-PCR.  Because an ~2-fold increase in knockdown potency was observed from 
both the eSIBR backbone and amiRNA chaining, we would expect an ~4-fold enhancement to 
potency-of-knockdown if both factors contributed independently to knockdown efficiency.  
However, we observed an ~3-fold increase when eSIBR amiRNAs were multimerized. Although 
more work is needed to determine molecular mechanisms responsible for this observation, it is 
possible that pri-miRNA processing efficiency hits a maximum level which is less than the 
maximum contribution from both the eSIBR backbone and linkage-based effect.  Indeed, we 
found that the combination of both factors caused only a modest further increase in pri-miRNA 
processing as compared to much larger individual contributions from chaining or the eSIBR 
backbone alone.  In further support of this notion, we determined that the lower than expected 
knockdown enhancement was not simply due to the eSIBR backbone interfering with the 
chaining effect; wtSIBR and eSIBR backbones similarly enhanced knockdown potency when 
multimerized.  Interestingly, effects on processing efficiency may be cell or species-dependent, 
because we observed an expected ~2-fold increase in knockdown potency when comparing triple 
eSIBR amiRNAs to triple wtSIBR amiRNAs in cultured rat hippocampal neurons, but only 
observed a 1.5-fold enhancement in our COS7 cell assays.     
Our results may also suggest that the eSIBR modifications or amiRNA chaining alter pri-
miRNA processing kinetics.  For example, the observed non-additive increase to knockdown 
potency from the combination of amiRNA chaining and the eSIBR backbone could be due to a 
reduction in pri-miRNA processing speed for eSIBR amiRNAs, but not wtSIBR amiRNAs, when 
concatenated.  Moreover, the idea of different processing speeds could explain why 1 out of 5 
amiRNAs tested (cadm2.87) did not exhibit a chaining-based enhancement of knockdown 
potency.  For instance, it is possible that the cadm2.87 hairpin had a higher basal processing rate 
than the other amiRNAs which was not further increased by amiRNA chaining. More work is 
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needed to investigate the exact influence of amiRNA concatenation and the eSIBR backbone on 
miRNA processing kinetics.   
We believe that the eSIBR backbone offers three distinct advantages over the miR-E 
scaffold (46).  First, the SIBR backbone may be intrinsically superior for multi-gene RNAi.  
Chung and colleagues previously demonstrated that chaining identical SIBR amiRNAs can 
enhance knockdown efficiency (11),  and we additionally observed here that concatenating 
amiRNAs which targeted different genes was sufficient to increase knockdown potency.  While 
this linkage-based enhancement has been seen for at least one other amiRNA backbone (9), 
effects of chaining miR-30-based amiRNAs are less consistent, and may even decrease amiRNA 
efficacy (40,80,81).     Importantly, knockdown improvement due to concatenation was retained 
in eSIBR amiRNAs, in addition to the enhancement provided by the backbone modifications.  
Taken together, these results establish the eSIBR backbone as a promising tool for multi-gene 
knockdown.  The second advantage of the eSIBR backbone is ease of cloning compared to the 
miR-E backbone, which requires de-novo synthesis of a 97-mer including the amiRNA target 
sequence and flanking optimized scaffold region (46).  The eSIBR backbone can be easily 
swapped to replace existing wtSIBR scaffolds by restriction enzyme digestion and ligation as 
described in the original report (11).  Furthermore, any previously designed SIBR amiRNAs can 
be inserted directly into the eSIBR backbone without the need to synthesize new sequences.  
Third, a recent breakthrough for functional zebrafish genetics used SIBR-based amiRNAs to 
create the first RNAi system to cause sufficient gene knockdown in this organism (82).  In the 
study, SIBR/mi-155-based amiRNAs vastly outperformed amiRNAs expressed from the 
endogenous zebrafish miR-30 backbone, which posits that SIBR-based amiRNAs may be more 
potent in general than amiRNAs expressed from the miR-30/E scaffolds.   It will be of large 
interest to determine if the eSIBR backbone can further enhance knockdown in zebrafish as this 
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may become an invaluable tool for an organism that currently has few methods for conditional 
loss-of-function studies.   
We offer here an outline for efficient multi-gene knockdown, from amiRNA design 
through implementation using the eSIBR backbone.  We showed the applicability of eSIBR-
based miRNAs by potently knocking down three members of a gene family in cultured neurons 
using a lentiviral expression system, demonstrating the eSIBR backbone as a useful tool for 
RNAi-based research.  We believe that the eSIBR backbone holds great promise for applications 
which may benefit from multi-target RNAi, such as tackling functional redundancy within gene 
families or even gene therapy-based methods requiring simultaneous knockdown of multiple 
genes.   
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CHAPTER III 
SYNCAMS FUNCTION REDUNDANTLY TO SHAPE EXCITATORY 
SYNAPSES 
 
The work presented here represents unpublished co-authored material.  This work was 
co-authored by myself, Carly Williams, Scott Stewart, Kryn Stankunas and Philip Washbourne. 
Carly Williams helped run many of the experiments. Scott Stewart and Kryn Stankunas 
developed many of the vectors for generation of lentiviral knockdown and rescue constructs.  
Philip Washbourne contributed to the experimental design and helped with editing the 
manuscript. I conceived the study and experimental design, ran the majority of the experiments, 
analyzed the data, and wrote the paper.  
 
INTRODUCTION 
Synaptogenesis, the process of synapse formation, is thought to be initiated by physical 
contact of adhesion molecules located on a presynaptic axon and postsynaptic dendrite of two 
different neurons (for review see Garner et al., 2002; Waites et al., 2005; Washbourne 2004). In 
addition to holding synapses together, interaction between adhesion molecules triggers the 
recruitment of distinct pre- and post-synaptic components.  In the case of excitatory synapses, 
which represent the vast majority of synapses in the mammalian central nervous system (CNS), 
this includes the recruitment of glutamate-filled synaptic vesicles to the presynaptic active zone 
as well as glutamate receptors and scaffolding molecules of the membrane-associated guanylate 
kinase (MAGUK) family to the postsynaptic density (PSD). The nectin-like synaptic cell 
adhesion molecule (SynCAM) family has joined an ever-growing list of adhesion molecules 
known to be important for synapse formation including neurexin/neuroligins, cadherins, NCAM, 
and Ephrin-EphR complexes (Tallafuss et al., 2010).   
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Genetically, genome-wide association studies strongly link SynCAMs, encoded by the 
cell adhesion molecule (CADM) genes (Thomas et al., 2008), to the occurrence of many higher-
order cognitive disorders such as autism (Zhiling et al., 2008), major depressive disorders and 
risk of suicide (Benton et al., 2012; Niculescu et al., 2015), and bipolar disorder (Redei et al., 
2014).  Additionally, SynCAM1 knockout mice have learning and memory deficits (Robbins et 
al., 2010) and display behaviors which parallel symptoms of autism and attention deficit 
hyperactivity disorder (ADHD) (Sandau et al., 2012; Takayanagi et al., 2010).  A better 
understanding of SynCAM function may prove useful for the treatment of these disorders. 
Mechanistically, SynCAMs display a potent ability to induce the formation of functional 
presynaptic terminals when presented to axons in vitro (Biederer et al., 2002; Czondor et al., 
2013; Hoy et al., 2009; Sara et al., 2005).  Beyond this ability, there is little agreement in the field 
about specific synaptogenic functions ascribed to SynCAMs.  For example, overexpression of 
SynCAM1 in vivo increased hippocampal excitatory synapse density (Robbins et al., 2010), but 
overexpression experiments in cultured neurons are contradictory with some reports showing an 
increase in synapse density (Cheadle and Biederer, 2012), while others reports, even from the 
same group, display no change (Burton et al., 2012; Fogel et al., 2007; Sara et al., 2005). Loss-of-
function experiments have similarly contradictory results.  Again in vivo, one study showed 
SynCAM1 knockout causes a small, but significant, decrease in spine and synapse density 
(Robbins et al., 2010).  Subsequent reports in culture with SynCAM1 knockout neurons or RNAi-
mediated SynCAM1 knockdown show conflicting effects on synapse density directly quantified 
by immunostaining for synaptic markers or indirectly measured through spine density (Burton et 
al., 2012; Cheadle and Biederer, 2012).  Despite a clear synaptogenic potential, the molecular 
mechanisms that SynCAMs use to form synapses remain unclear, and there is a need to reconcile 
gain- and loss-of-function phenotypes in order to characterize synaptic functions of SynCAMs.   
43 
 
A possible reason for a lack of mechanistic understanding of SynCAM function, and for 
studies of synaptogenic processes in general, is functional redundancy.  In many cases 
characterizing molecular functions at synapses is precluded not only by massive overlap in 
signaling pathways and binding partners (Dalva et al., 2007; Kim and Sheng, 2004; Scheiffele, 
2003), but also by functional redundancy within gene families themselves. Importantly, 
compensatory functions from additional family members or different adhesion molecules may 
hide crucial synaptic functions when manipulating individual genes. Indeed, redundancy has been 
observed for neurexins, neuroligins, calsyntenins, and MAGUKs, such that for each of these gene 
families protein reduction of at least three members is necessary to observe certain synaptic 
phenotypes (Gokce and Sudhof, 2013; Levy et al., 2015; Shipman et al., 2011; Um et al., 2014).  
SynCAMs have four members (SynCAM1-4) that can form homo- or hetero-philic interactions in 
trans across the synaptic cleft, and are also among the first proteins found at a nascent synapse 
(Biederer, 2006; Fogel et al., 2007; Stagi et al., 2010).  SynCAM1-3 have been found both pre- 
and post-synaptically at excitatory synapses (Cheadle and Biederer, 2012; Fogel et al., 2007; Shu 
et al., 2011) and make up approximately 0.5% of the protein content of a synapse (Robbins et al., 
2010). The short intracellular regions of SynCAM1, 2 and 3, which are necessary for 
synaptogenic activity (Biederer et al., 2002; Sara et al., 2005), contain remarkably conserved 
single FERM and PDZ binding motifs and most likely interact with the same proteins during 
development (Biederer, 2006). Therefore compensation between SynCAMs may hinder their 
functional characterization at synapses. 
Here we present a novel analysis method for overcoming functional redundancy which 
we call Mosaic Expression using Differentially-Localized Reporters (MEDLR).  MEDLR uses 
combinatorial lentiviral transgenesis with different subcellularly-localized GFP reporters linked 
to gene knockdown or overexpression constructs.  Multi-gene knockdown is achieved through the 
use of RNAi targeting sequences expressed from enhanced artificial miRNA (amiRNAs) 
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backbones which are chained in tandem in the same expression cassette (Fowler et al., 2015), 
making MEDLR especially suitable to address functional redundancy.  This method generates 
traceable mosaic gene expression patterns and allows dissection of cell-autonomous from non 
cell-autonomous effects.  Crucially, in neurons this allows the differentiation of pre-and post-
synaptic effects due to genetic gain or loss-of-function.  Using MEDLR, we find that SynCAMs 
are necessary for and function redundantly to set excitatory synapse number and size in cultured 
rat hippocampal neurons through a postsynaptic mechanism.   
 
RESULTS 
Generation of lentiviral gain- and loss-of-function constructs 
 In an attempt to reconcile gain- and loss-of-function effects for multiple SynCAM protein 
isoforms, we developed a rapid method to generate lentiviral knockdown and overexpression 
vectors based on Multi-site Gateway (Invitrogen) recombination cloning.  This method allows for 
insertion of up to three independent elements in series from 5’, middle, and 3’ entry vectors into a 
lentiviral destination vector containing additional sequences necessary for production and 
efficient packing of viral RNA transcripts into mature lentiviral particles via LR-clonase 
recombination reactions (Figure 1A).  The lentiviral destination vector (pLentiDest_inverse) 
promotes viral RNA transcription in an antisense orientation compared to the inserted elements, 
and allows for enhanced lentiviral packaging by preventing same-strand promoter competition 
between the viral RSV promoter and the inserted entry elements (Schambach et al., 2006).   
 Lentiviral-mediated knockdown is achieved through the use of amiRNAs expressed from 
an enhanced synthetic inhibitory BIC/miR-155 RNA (eSIBR) backbone (Fowler et al., 2015).  
Importantly, these amiRNA cassettes can be chained for potent, simultaneous multi-gene 
knockdown, and are expressed from an intron upstream of nuclear-localized GFP (nlsGFP) which 
prevents amiRNA cleavage from affecting reporter expression levels.  Lentiviral knockdown 
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vectors are generated with a minimal CMV promoter in a 5’ entry vector, intronic single or 
chained amiRNAs in a middle entry vector, and nlsGFP in a 3’ entry vector following 
recombination with pLentiDest_inverse (Figure 1B).  These vectors allow for traceable 
knockdown via a nuclear GFP reporter.  To label neuronal dendrites, we used a previously 
developed middle entry vector with membrane-targeted GFP (Kwan et al., 2007) to generate a 
lentiviral vector only expressing memGFP (Figure 1C).     
Additionally, to generate lentiviral rescue or overexpression vectors also co-expressing 
the memGFP reporter, we developed new entry vectors with memGFP and the porcine 
teschovirus-1 2A sequence (P2A) in both the middle and 3’ entry vectors for addition to rescue 
construct N- or C-termini, respectively (Figure 1D).  This allows for 1:1 bicistronic expression of 
two independent proteins translated as a single polypeptide because of the “self-cleaving” ability 
of the P2A peptide sequence (Kim et al., 2011).  Therefore, these vectors allow for traceable 
overexpression with a membrane-localized reporter.   
 
Lentiviral-mediated knockdown ablates SynCAM1-3 protein expression 
We created a lentiviral construct which co-expressed nlsGFP and chained eSIBR 
amiRNAs targeting SynCAM1, 2 and 3 (SynCAM1-3 amiRNA-nlsGFP) to test the ability of  
_________________ 
Figure 1 (next page).  Rapid generation of lentiviral knockdown and overexpression vectors.   
(A) 5’, middle, and 3’ entry vectors are recombined in series via att recombination sequences into 
a lentiviral destination vector which promotes viral RNA transcription antisense to inserted 
elements (pLentiDest_inverse).  Purple boxes represent viral-specific sequences.   
(B)  Lentiviral knockdown vectors are generated with a 5’ CMV promoter, intronically expressed 
amiRNAs in a middle entry vector, and 3’ nuclear-localized GFP (nlsGFP). 
(C) A vector for dendrite labeling is created with CMV promoted membrane-localized GFP 
(memGFP). 
(D).  Lentiviral overexpression/rescue vectors are generated with a CMV promoter and either N- 
or C-terminal addition of P2A-linked memGFP to the rescue construct for bicistronic expression 
and dendrite labeling with memGFP. LTR, long-terminal repeat, RRE, Rev-response element, 
cPPT, central polypurine tract, WPRE, woodchuck hepatitis virus posttranscriptional regulatory 
element, ccdB, control of cell death type II toxin-antitoxin system B, CmR, chloramphenicol 
resistance, P2A, porcine teschovirus-1 2A sequence.    
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amiRNA-based lentiviral vectors to knock down SynCAM1-3 protein levels in cultured rat  
hippocampal neurons (Figure 2A).  Neurons were infected with SynCAM1-3 amiRNA-nlsGFP at 
1-2 days in vitro (DIV) with lentivirus at a multiplicity of infection (MOI) of 20 to cause 
saturating transduction (>99% of cells, data not shown). We used quantitative real-time PCR 
(qPCR) to compare cadm1-3 mRNA transcript levels in 13-15 DIV cultures, which showed 
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lentiviral-mediated knockdown reduced cadm1-3 levels ~75-90% compared to uninfected control 
cultures (Figure 2B).  We also investigated knockdown potency by quantitative Western blotting 
using an antibody specific to the c-terminus of SynCAM1-3 (Biederer et al., 2002), but which 
does not recognize SynCAM4 (Fogel et al., 2007) (Figure 2C).  We again infected neurons at 1-
2DIV with SynCAM1-3 amiRNA-nlsGFP lentivirus or control lentivirus carrying scrambled 
SynCAM1-3 amiRNA guide sequences targeting no known genes (Scrambled1-3 amiRNA-
nlsGFP) and compared SynCAM1-3 protein levels at 13-15DIV.  At an MOI of 20, overall 
SynCAM1-3 levels in SynCAM1-3 amiRNA-nlsGFP infected cultures were significantly 
decreased by 89 ± 1% compared to cultures infected with scrambled amiRNAs (Figure 2D).  
Together, these results demonstrate that lentiviral amiRNA-based knockdown can robustly and 
simultaneously decrease the levels of SynCAM1-3 in culture.   
We also monitored SynCAM1-3 knockdown by quantitative Western blotting in cultures 
infected with SynCAM1-3 or Scrambled1-3 amiRNA-nlsGFP at an MOI of 2 (Figure 2C), which  
produced sub-saturating transduction rates of 80-90% (data not shown).  At this MOI, SynCAM1-
3 protein levels were significantly reduced by 67 ± 3% compared to control cultures (Figure 2D).  
Because of the sub-saturating conditions, we speculated that the knockdown efficiency observed  
_________________ 
Figure 2 (next page).  amiRNA-mediated knockdown ablates SynCAM1-3 protein expression. 
(A)  Schematic of lentiviral knockdown vector which expresses chained amiRNAs targeting 
SynCAM1, 2 and 3 from an intron, followed by a nuclear-localized GFP reporter (SynCAM1-3 
amiRNA-nlsGFP).   
(B)  Comparison of cadm1-3 mRNA levels by qRT-PCR in cultured rat hippocampal neurons 
relative to levels in uninfected control cultures. n=2 independent experiments. 
(C) Representative quantitative Western blots and  
(D) Relative SynCAM1-3 protein levels measured by quantitative Western blotting of cultured 
neuron following indicated amiRNA lentiviral treatments at different multiplicity of infection 
(MOI) relative to Scrambled1-3 amiRNA control treatments.  n=4 (MOI=20) or n=2 (MOI=2) 
independent experiments. Actin was used as a loading control.   
(E) Representative images and 
(F) Quantification of relative SynCAM1-3 immunofluorescence of individual neurons cultured at 
low density normalized to immunofluorescent intensity of control Scrambled1-3 amiRNA treated 
neurons.  Scrambled1-3 condition n=13 cells, SynCAM1-3 condition n=20 cells.   
All error bars represent s.e.m. 
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by Western blotting likely underrepresented knockdown efficiency in individual nlsGFP-positive  
cells.  To address this possibility, we cultured neurons at very low density using the same sub-
saturating transduction rate with SynCAM1-3 or Scrambled1-3 amiRNA-nlsGFP lentivirus.  
Additionally, neurons were co-infected with memGFP-only lentivirus to label individual cells for 
imaging.  Cells were fixed and stained with the SynCAM1-3 antibody and an antibody for GFP at 
13-15DIV, and overall SynCAM1-3 fluorescence in individual cells co-expressing nlsGFP and 
memGFP was measured (Figure 2E).  When normalized to mean fluorescence levels in cells 
infected with Scrambled1-3 amiRNAs, SynCAM1-3 amiRNAs reduced mean SynCAM1-3 
protein levels by 95 ± 2% (Figure 2F).  This shows that SynCAM1-3 expression is effectively 
ablated by lentiviral-mediated amiRNA expression, even in sub-saturating rates of viral 
transduction.     
 
Generation of an assay to compare SynCAM gain- and loss-of-function effects 
We developed an assay which we termed Mosaic Expression with Differentially 
Localized Reporters (MEDLR) to dissect SynCAM knockdown and overexpression effects in 
cultured rat hippocampal neurons (Figure 3A).   We infected dense neuronal cultures for imaging 
with knockdown lentiviral vectors at an MOI of 2 in order to achieve an ~80-90% overall 
transduction rate with the nlsGFP reporter.  We additionally infected cells with an MOI of 0.01 
with either memGFP-only lentivirus (Combination 1, Figure 3A) or memGFP rescue vectors with 
hemagluttanin (HA) epitope-tagged SynCAM rescue constructs (Combination 2, Figure 3A) to 
label a subset (~1%)  of neurons with memGFP reporter for dendritic imaging.  Therefore, 
memGFP-positive cells that were also nlsGFP-positive marked SynCAM knockdown neurons 
when combined with memGFP-only lentivirus. Similarly, memGFP and nlsGFP-positive cells 
had rescued SynCAM expression when the memGFP-HA-SynCAM rescue lentivirus was used.  
Crucially, because cells are transduced at a subsaturating concentration of nlsGFP-knockdown 
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lentivirus, this combinatorial approach allowed for the analysis of only memGFP-positive cells 
with SynCAM expression levels distinct from their in-condition memGFP/nlsGFP double 
positive counterparts.  When the memGFP-only lentivirus or memGFP-HA-SynCAM rescue 
lentivirus were applied, memGFP-only positive cells therefore expressed wild type or 
overexpressed levels of SynCAMs, respectively.   Thus, these two viral combinations generate 
differential mosaics of SynCAM expression with four classes (knockdown, wild type, rescue, and 
overexpression) which are linked to traceable subcellularly-localized GFP reporter patterns.  One 
important consequence is that different expression levels can be compared on the same coverslip, 
ensuring cells were subjected to identical treatments. These advantages over traditional single-
marker methods highlight MEDLR as a particularly suitable tool to directly compare gain- and 
loss-of-function effects in the same system.   
Labeling a small subset of neurons with memGFP allowed unfettered imaging of cellular 
substructures, such as dendrites (Figure 3B).  To compare differences in SynCAM-mediated 
synapse formation along dendrites, we developed a semi-automated program to pair with 
MEDLR which measures synaptic parameters such as synapse density, size, and intensity in 
cultures immunostained for pre- and post-synaptic markers (Figure 3C).  Following manual 
selection of dendrites, this method uses per-dendrite thresholding for detection of pre- and post-
synaptic puncta. Using this program, synapses are defined as co-localized regions of pre- and 
post-synaptic puncta (white in Merge image, Figure 3C). 
_________________ 
Figure 3 (next page).  Mosaic expression with differentially localized reporters (MEDLR). 
(A) Overview of MEDLR approach.  Two lentiviral combinations provide four traceable cellular 
populations with distinct protein expression levels. 
(B) Representative 60X confocal microscopy image of MEDLR combination 1 as in (A) of 
cultured rat hippocampal neurons treated with Scrambled1-3 amiRNA-nlsGFP, with an individual 
pyramidal cell co-labled by memGFP and nlsGFP marked by a red arrowhead.  White arrowheads 
mark nuclei in the field of view only expressing nlsGFP.   
(C) Sample images of automated puncta and synapse detection from co-immunostaining for 
presynaptic marker Synapsin1 and  postsynaptic marker PSD-95 following manual selection of an 
individual dendrite segment from the image in (B).  Synapses are defined as the co-localized 
regions of pre- and post-synaptic puncta (white areas in merged image). 
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SynCAM1-3 knockdown reduces synapse density and increases synapse size 
 We used MEDLR to measure differences in synapse formation caused by SynCAM1-3 
knockdown in cultured hippocampal neurons.  Neurons were co-infected with memGFP-only 
virus for cellular labeling and with SynCAM1-3 or Scrambled1-3 amiRNA-nlsGFP lentivirus at 
1-2DIV.  Neurons were fixed and immunostained for GFP, the presynaptic marker Synapsin1, 
and the postsynaptic marker PSD-95 at 13-15DIV.  Dendrites of memGFP-only and 
memGFP/nlsGFP double positive cells were imaged and analyzed using our puncta detection 
software (Figure 4A).  MEDLR showed that SynCAM1-3 knockdown caused a modest, but 
significant, reduction of Synapsin1/PSD-95 synapse density by 16 ± 5% (Figure 4B), which is 
consistent with modest decreases in synapse density observed following SynCAM1 knockout 
(Cheadle and Biederer, 2012; Robbins et al., 2010). Furthermore, because SynCAM1-3 levels 
were reduced more than 95% by amiRNAs, this modest decrease suggests that SynCAM1-3 may 
play a role in fine-tuning synapse number.  Additionally, SynCAM1-3 knockdown did not alter 
individual Synapsin1 or PSD-95 puncta density on dendrites (data not shown), implying that the 
observed phenotype is specific to transynaptic complexes with both pre- and postsynaptic 
structures.  
_________________ 
Figure 4 (next page).  MEDLR uncovers novel synaptic phenotypes caused by SynCAM1-3 
knockdown. 
(A) Representative images of automated PSD-95, Synapsin1, and synapse (merged) puncta 
detection for manually-selected dendrite segments of cultured hippocampal pyramidal cells using 
MEDLR. 
(B) Relative synapse density (synaptic puncta/dendrite length) and synapse size for dendrites of 
pyramidal cells treated as in (A) normalized to mean values of the Scrambled1-3 amiRNA 
nlsGFP+ control group.   
(C) Cumulative frequency and 
(D) Histogram of frequencies of relative synapse density for dendrite segments of cells from 
treatments as in (A).  Relative synapse densities were normalized to mean values of the 
Scrambled1-3 amiRNA nlsGFP+ control group and binned in 10% intervals from 0 to 2, which 
included all dendrites. 
(B – D) *p<0.05, **p<0.01, pairwise student’s t-tests, n=4 independent experiments (14-20 
dendrites per treatment group per experiment).  Error bars represent s.e.m. 
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Unexpectedly, we found that SynCAM1-3 knockdown caused an ~25% increase in 
synapse size (Figure 4B), but due to high variability in this phenotype from culture-to-culture this 
phenotype was not statistically significant (p=0.17).  Nevertheless, this trend is opposite to an 
observed decrease in synapse size in SynCAM1 knockout mice (Robbins et al., 2010).  This result 
may therefore indicate a new phenotype specific to SynCAM1-3 knockdown, and may suggest 
SynCAM isoform-specific roles in shaping excitatory synapse size.  In contrast to the synaptic 
density phenotype, SynCAM1-3 knockdown produced non-significant increases in both PSD-95 
and Synapsin1 individual puncta size (data not shown).   Together, these results suggest 
independent mechanisms for the influence of each SynCAM on synapse density and size.  
 
A postsynaptic, dendrite-specific mechanism for SynCAM-mediated synapse formation 
When combining nlsGFP knockdown lentivirus with memGFP-only lentivirus, MEDLR 
affords the direct comparison of phenotypes in wild-type (memGFP positive only) and 
knockdown (memGFP/nlsGFP double positive) neurons in the same culture.  With this specific 
combination, the comparison of these distinct cell populations allows discrimination of cell-
autonomous from non cell-autonomous effects produced from SynCAM1-3 protein knockdown 
because a cell non-autonomous phenotype is expected to occur, at least partially, in the wild-type 
population.  This is because the majority of axons impinging on wild-type (memGFP only) 
neurons should have reduced levels of SynCAM1-3 because they are from neurons transduced 
with SynCAM1-3 amiRNAs.  memGFP-only expressing wild-type cells in both Scrambled1-3 
and SynCAM1-3 amiRNA conditions did not show a reduction in either synapse density or size 
(Figure 4B), suggesting that the observed decrease in synapse density and increase in synapse 
size from SynCAM1-3 knockdown is a cell-autonomous effect.  Importantly, these results also 
suggest that the observed phenotypes due to SynCAM1-3 knockdown are generated through a 
postsynaptic mechanism for the same reason that even though the majority of axons in culture 
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have reduced SynCAM1-3 levels, this does not affect their ability to form synapses onto wild-
type cells in the same culture condition.     
We investigated the reduced synapse density phenotype observed in SynCAM1-3 
knockdown neurons in more detail by binning dendrite synapse density in 10% intervals relative 
to the mean synapse density in control Scrambled1-3 amiRNA memGFP/nlsGFP double positive 
neurons for each experiment, then averaging the binned values from 4 independent experiments.  
As expected, the cumulative frequency for relative synapse numbers on dendrites of SynCAM1-3 
knockdown neurons shifted to significantly smaller densities compared to controls, but there was 
no change between control memGFP/nlsGFP double positive Scrambled1-3 amiRNA expressing 
cells or memGFP-only expressing wild-type cells in either amiRNA treatment condition (Figure 
4C).  However, when presented as a histogram, we were surprised that SynCAM1-3 knockdown 
did not cause a modest overall shift in relative synapse density frequency, but rather produced a 
sharp increase in the numbers of dendrite sections which had 40-70% less synapses than the 
Scrambled1-3 amiRNA control mean (Figure 4D), while leaving the overall distribution relatively 
unchanged.  This result suggests that SynCAM1-3 selectively functions in a subset of dendrites, 
and therefore may represent a novel mechanism for dendrite specialization or synapse specificity. 
 
SynCAM1-3 are functionally redundant 
 Finally, we generated lentiviral knockdown vectors with all possible combinations of 
single and double knockdowns, and tested their ability to recapitulate the SynCAM1-3 
knockdown phenotypes in cultured neurons (Figure 5A).  No single or double knockdown of 
SynCAM1-3 caused a change in synapse density or size when compared to control Scrambled1-3 
amiRNA expressing neurons (Figure 5B and C).  These results show that SynCAM1-3 are 
functionally redundant for influencing synapse density and synapse size.   
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Figure 5.  SynCAM1-3 are functionally redundant to set synapse density and size. 
(A) Cultured neurons were infected with lentivirus carrying all possible combinations of 
SynCAM1-3 amiRNAs or Scrambled1-3 control amiRNAs. 
(B) Relative synapse density and 
(C) Relative synapse area normalized to mean values for Scrambled1-3 amiRNA treated neurons.   
(B-C) p<0.05, pairwise student’s t-tests, n=4 independent experiments for SynCAM1-3 and 
Scrambled1-3 amiRNA conditions, n=2 independent experiments for all others.  Error bars 
represent s.e.m. 
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DISCUSSION 
The SynCAM family of cell adhesion molecules has been frequently demonstrated to 
have an innate synaptogenic potential.  However, due to inconsistent reported synaptic 
phenotypes of SynCAMs in gain- and loss-of-function experiments, currently there is no detailed 
function ascribed to SynCAMs for the process of synapse formation.  A potential reason why 
variable phenotypes are observed is functional redundancy between SynCAM family members.   
Here we present a novel method, MEDLR, which we use to thoroughly characterize functional 
consequences of SynCAM1-3 knockdown.  We find that robust knockdown (95%) of SynCAM1-
3 isoforms modestly decreases synaptic density as measured by immunostaining for pre- and 
postsynaptic marker proteins, and that SynCAM1-3 knockdown tends to increase synaptic size. 
This contrasts with observed decreases in synapse size in SynCAM1 knockout mice in vivo 
(Robbins et al., 2010).  Intriguingly, MEDLR showed that these phenotypes were a postsynaptic 
effect, which is a conclusion not attainable by single-marker knockdown analysis.  Finally, we 
show that the three SynCAMs a function redundantly in these processes because only removal of 
all three produced these phenotypes.  Together, these results demonstrate that SynCAM1-3 
function redundantly through postsynaptic mechanisms to regulate excitatory synapse number 
and size. 
Using MEDLR to simultaneously knock down SynCAM1-3 protein expression in 
cultured rat hippocampal neurons, we observed a modest, but significant, decrease in synapse 
density on pyramidal cell dendrites monitored by immunostaining for pre- and post-synaptic 
proteins.  Importantly, only removal of all three SynCAMs reduced synapse density, showing that 
SynCAM1-3 are functionally redundant to set synapse number in vitro.  When combined with 
reports of modestly decreased synapse density due to SynCAM1 knockout in vitro and in vivo 
(Cheadle and Biederer, 2012; Robbins et al., 2010), this result is consistent with a model in which 
there is a “threshold” level of SynCAMs for normal function.  This model may also explain the 
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lack of a synaptic phenotype when using RNAi methods to knock down SynCAM1.  For 
example, we did not see a phenotype by amiRNA-mediated knockdown of only SynCAM1, nor 
did a previous study which used short-hairpin RNAs (shRNAs) (Burton et al., 2012).  
Accordingly, functional levels of SynCAM1 may still be present due to incomplete removal of 
SynCAM1 through RNAi-based methods as compared to SynCAM1 knockout mice.  It should be 
noted, however, that our amiRNA-mediated knockdown of SynCAM1 reduced >90% of mRNA 
levels and had a similarly robust effect on SynCAM1 protein levels (data not shown), yet no 
synaptic phenotypes, or even trends, were observed.  Nevertheless, data presented here supports a 
function of SynCAMs in fine-tuning excitatory synapse density, rather than playing a 
fundamental role in synapse formation.  
Unexpectedly, we observed that SynCAM1-3 knockdown tended to increase synapse 
size.  SynCAM1-3 also functioned redundantly to alter synapse size, because removal of 
SynCAM1-3 was necessary to observe this phenotype.  This is in juxtaposition to decreased 
synapse size reported in SynCAM1 knockout mice (Robbins et al., 2010).  One explanation for 
this contrast may arise from inherent differences in synapse formation in vivo compared to in 
culture, as was studied here.  Another possibility, however, is that synapse size is influenced 
differently by SynCAM gene family members such that removal of SynCAM1-3 produces an 
opposing effect compared to only SynCAM1 depletion.  For instance, an isoform-specific binding 
interaction of Farp1 on the FERM motif of SynCAM1, which remains the only demonstrated 
SynCAM synaptic signaling mechanism, mediates SynCAM1’s influence on synapse density and 
dendritic spine shape (Cheadle and Biederer, 2012).  Therefore, it remains to be seen if SynCAM-
specific mechanisms exist which regulate synapse size.   
Use of MEDLR allowed us to conclude that SynCAM1-3 function postsynaptically to 
influence synapse number and size.  This was surprising because we expected that knockdown of 
SynCAM1-3 in the majority of cultured neurons would generally decrease their ability to form 
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presynaptic terminals, since ectopic SynCAMs can potently induce presynaptic terminal 
formation.  However, this was not observed because wild-type cells in the SynCAM1-3 
knockdown cultures did not exhibit a change in synapse density or size.  This instead argues that 
SynCAM1-3 influence excitatory synapse formation, including presynaptic development, via 
postsynaptic mechanisms.  This notion is supported by data from the previously mentioned study 
which demonstrated that Farp1 functions specifically through SynCAM1 in the postsynapse to 
transsynaptically regulate presynaptic density (Cheadle and Biederer, 2012).  A mechanism of 
postsynaptically-mediated transsynaptic signaling is corroborated by data presented here which 
show that SynCAM1-3 knockdown affects only colocalized Synapsin1/PSD-95 puncta, but does 
not affect individual puncta density.  Taken together, these results provide strong evidence that 
SynCAMs function postsynaptically to mediate formation of both pre- and postsynaptic 
structures. 
In depth analysis of the synapse density phenotype produced by SynCAM1-3 knockdown 
showed that there is not an overall decrease in synapse density across all dendrites, but rather that 
a subset of dendrites in cells lacking SynCAM1-3 have a more severe decrease in synapse 
density.  This exciting result implies that SynCAMs function specifically in a subset of dendrites. 
Alternatively, this may suggest that SynCAM1-3 knockdown only produces a phenotype in a 
subset of pyramidal cells, as our cultures are made from a heterogeneous mixture of hippocampal 
neurons.  Further investigation will be necessary to determine why SynCAM1-3 knockdown 
seems only to affect a subset of pyramidal cell dendrites.    
More generally, here we offer tools for rapid generation of lentiviral knockdown and 
overexpression vectors and present a novel method, MEDLR, which, with a method for 
semiautomated analysis of immunostained synaptic markers, enables analysis following gain-and 
loss-of-function experiments in cultured neurons.  Because the knockdown vectors make use of 
chained amiRNAs, these constructs are well suited to address functional redundancy. Futher, 
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additional controls afforded by MEDLR allow for informative comparisons of distinct cellular 
populations which is not possible by single-marker analysis methods.  In cultured neurons, this 
includes comparison of cell autonomous and non cell-autonomous effects and differentiation of 
pre- and post-synaptic mechanisms. Together, the tools and methods presented here should help 
accelerate the functional characterization of synaptic proteins.   
 
MATERIAL AND METHODS 
Cloning 
Lentiviral knockdown vectors. Creation of artificial miRNAs targeting SynCAM1-3 and 
Scrambled1-3 amiRNAs, a Multi-site Gateway middle entry vector with an intronically-expressed 
enhanced SIBR amiRNA cloning cassette (pME-eSIBR_intron), a 5’ entry vector with a minimal 
CMV promoter (p5E-CMVmin) and anti-sense promoted CMV-amiRNA-nlsGFP lentiviral 
vectors for SynCAM1-3 knockdown was previously described (Fowler et al., 2015).   
Lentiviral membrane-targeted GFP reporter.  An HA-epitope tag sequence followed by a stop 
codon was amplified and inserted into the 3’ entry vector pDONR P2R-P3 to make p3E-HA-stop.  
A previously described middle entry vector containing GFP with a C-terminal human H-RAS 
palmitoylation signal for membrane targeting (Kwan et al., 2007) was used with p5E-CMVmin 
and p3E-HA-stop to generate a lentiviral destination vector pLentiDest_inverse-CMVmin-
memGFP.  The HA epitope is not expressed because the GFP sequence used contains a stop 
codon and was therefore used as an “empty” 3’ element to allow LR recombination.   
Lentiviral rescue vectors.  To generate a 3’ entry vector containing the viral P2A peptide in frame 
to the N-terminal of  memGFP (p3E-P2A-memGFP), we first cloned a p3E-P2A-MCS (multi-
cloning site) vector.  GFP with a C-terminal human H-RAS palmitoylation signal for membrane-
targeting was amplified by PCR cloned into p3E-P2A-MCS to make p3E-P2A-memGFP.  To 
generate a middle entry vector containing memGFP-P2A (pME-memGFP-P2A) we amplified 
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GFP with an N-terminal Fyn myristoylation site for dendritic membrane targeting (Kameda et al., 
2008) and without a stop codon into pcDNA3 make pcDNA3-memGFP.  We then inserted the 
P2A sequence 3’ of memGFP in pcDNA3-memGFP to make pcDNA3-memGFP-P2A. memGFP-
P2A was then amplified and inserted into pDONR221 to create pME-memGFP-P2A. All LR 
reactions were performed with a Gateway-compatible third generation lentiviral destination 
vector kindly provided by Dr. Kryn Stankunas (University of Oregon). 
 
Lentivirus.  Production and titering of lentivirus was previously described (Fowler et al., 2015).   
 
Neuron culture.  For single-cell SynCAM immunofluorescence comparisons, 3000 cells/well of a 
12-well plate of dissociated hippocampal neurons were cultured as previously described (Fowler 
et al., 2015). For all other experiments, cells were cultured at a density of 100,000 cells/well of a 
12-well plate.  For imaging experiments, neurons were cultured on glass coverslides coated with 
poly-l-lysine. Neurons were infected with lentivirus at 1-2DIV.  Neurons were lysed for Western 
blot analysis, RNA extraction, or fixed for immunostaining at 13-15 DIV.  A detailed description 
of culturing conditions has been described previously (Fowler et al., 2015).  Studies were 
conducted in accordance with University of Oregon Institutional Animal Care and Use 
Committee protocols and in compliance with NIH guidelines for the care and use of vertebrate 
animals.   
 
Immunostaining.  Cells on glass coverslides were fixed with 4% paraformaldehyde and 4% 
sucrose in PBS for 15 min at 4°C.  Cells were then permeabilized for 5 min with 0.25% Triton-
X100 in PBS, and blocked for 1hr at RT with blocking solution (1% Roche blocking solution 
(Roche), 10% BSA, 1% normal donkey serum, and 1% normal goat serum in PBS).    Cells were 
then incubated with primary antibodies in blocking solution overnight at 4°C. Primary antibodies 
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and dilutions used were rabbit anti-Synapsin1 1:500 (EMD Millipore, AB1543), mouse anti-PSD-
95 1:350 (Neuromab, clone K28/43), and chicken anti-GFP 1:2000 (Aves Labs, GFP-1020), and 
anti-SynCAM1-3 1:500 (Pierce, PA3-16744).   The next day, cells were washed 3 x 5 min with 
PBS and incubated with secondary antibody in blocking solution for 1hr at RT. All secondary 
antibodies were from Jackson Laboratories and used at 1:500: goat anti-chicken Alexa Fluor 488, 
donkey anti-mouse or anti-rabbit Cy3, and donkey anti-rabbit Cy5.  Cells were washed 3 x 5 min 
with PBS and mounted on slides with Fluoromount G with DAPI (Southern Biotech).   
 
Western blotting.  Quantitative western blotting for SynCAM1-3 has been previously described 
(Fowler et al., 2015).   
 
qRT-PCR.  First-strand cDNAs were synthesized from total RNA isolated from cultured 
hippocampal neurons using Superscript III reverse transcriptase (Invitrogen).  cDNAs were 
created using oligodT primers for 50 minutes at 50°C. Primer pairs used to measure cadm mRNA 
levels were cadm1_F: 5’-GAAGGACAGCAGGTTTCAGC-3’, cadm1_R: 5’-
ACCAGGACTGTGATGGTGGT-3’, cadm2_F: 5’-TCCTGATCGAATGGTTGTGA-3’, 
cadm2_R: 5’-TGGGATCGTGTACAATGAGG-3’, cadm3_f: 5’-
CCTGGAGAAAAGGTGACCAA-3’, cadm3_R: 5’-ATGGTTCACAGAGCACACGA-3.  qRT-
PCR was performed using SYBR Green reagents (Kapa Biosystems) using standard parameters 
on a StepOnePlus Real-Time PCR System (Applied Biosystems).  Values and relative expression 
levels were compared using the ∆∆Ct method. 
 
Imaging.  Neurons were imaged on an inverted Nikon TU-2000 confocal microscope using EZ-
C1 software.  For single-cell comaprisons of SynCAM1-3 immunofluorescence, images were 
obtained using a 20X DIC objective (0.75 NA).  For other experiments, images were obtained 
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using a 60X water immersion objective (1.2 NA) or 100X oil immersion objective (1.45 NA).  
For all experiments, the coverslip was scanned for cells to image using a 10X DIC objective.  The 
presence or absence of nlsGFP was validated by visual comparison of DAPI and GFP staining.  
For single-cell SynCAM1-3 immunofluorescence experiments up to 20 neurons that did not 
overlap with neighboring cells were selected for imaging for each condition. Eight neurons were 
imaged for a secondary-only condition for analysis of background fluorescence. Sequential 
scanning for each channel (488, 543 nm) was performed and the average of three images was 
taken at 1024 x 1024 pixel resolution.  For all other experiments, pyramidal cells were selected by 
morphology and cells were imaged if they had 2-3 primary or secondary basal dendrites with no 
further branches in a single field of view at high magnification that were visually discernable 
from additional GFP-positive processes and background immunofluorescence.  Sequential 
scanning for each channel (488, 543, 633 nm) was performed and the average of three images 
was taken at 2048 x 2048 pixel resolution.  For all experiments, images were obtained with 
constant pinhole, laser intensity, and detector gain settings.   
 
Image analysis. Each confocal image channel was saved independently as a greyscale 16-bit  
TIFF file.  For single-cell SynCAM1-3 knockdown comparisons, binary masks were made of 
each neuron using Image-Pro 6.3 software (Media Cybernetics) using outlines from 488nm 
images. Background debris was cleared from the masks manually using GIMP 2 software (The 
GIMP Team, 2015). SynCAM immunostaining intensity was calculated within the confines of the 
outline of the neuron defined by the binary masks using a custom program in MATLAB 
(Mathworks). The average fluorescence intensity for neurons in the secondary antibody only 
condition was used to measure background signal and was subtracted from the SynCAM staining 
intensity for each image. For dendrite analysis, using 488 nm images, individual basal dendrite 
segments averaging ~30 µm in length were selected and binarized manually using Image-Pro 6.3 
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software.  Binary masks were then used in a custom MATLAB program to automatically detect 
and compare puncta from corresponding 543nm and 633nm images.  Briefly, the program 
calculated the average fluorescent intensity of corresponding images in the binarized GFP region, 
set a threshold for including pixels in puncta detection (1.5X the mean value for each dendrite), 
and automatically detected puncta that were >4 continuous pixels.  Only puncta that overlapped 
with the binarized dendrite images were counted for comparison.  Overlapping pre- and 
postsynaptic puncta were counted as synapses.  Dendrite lengths were measured manually using 
Image-Pro 6.3 software.  Synapse density was calculated by dividing number of detected synaptic 
puncta by dendrite length.  Synapse area was reported by our custom program.   
 
Statistics.  Two-tailed student’s t-tests were performed in Microsoft Excel. 
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CHAPTER IV 
CONCLUSIONS 
 
 
The functional characterization of synaptic proteins has proven difficult for many 
reasons.  Along with the difficulty of working with neurons, which are among the most fragile 
cell type, massive compensatory signaling and functional redundancy at developing synapses 
coupled with a lack of versatile tools and methods to generate and compare subtle changes to 
synapse morphology have hampered many attempts to describe molecular mechanisms of 
synaptogenic genes.   
Throughout this dissertation, I described the development of tools to help accelerate and 
ease research on the mechanisms of synapse formation.  In chapter II, I enhanced the knockdown 
potency of an artificial miRNA expression system.  In addition to serving as a novel and efficient 
tool for multi-gene knockdown and the potential use for tackling functional redundancy at 
synapses, development of this enhanced amiRNA backbone led to a few unexpected discoveries.  
First, analysis of a large set of empirically-designed amiRNAs uncovered sequence-specific and 
structural features associated with efficient sequences.  Further, I discovered a novel linkage-
based enhancement mechanism whereby chaining amiRNAs targeting different genes increased 
knockdown potency through enhanced microprocessor cleavage.   
In Chapter III, I adapted the enhanced amiRNA system to address functional redundancy 
of SynCAMs in synapse formation.  Using the enhanced amiRNAs, I describe the rapid 
generation of lentiviral knockdown vectors.  Using these vectors to knockdown SynCAM1-3 
expression in cultured rat hippocampal neurons, I developed a novel combinatorial lentiviral 
assay with different subcellularly-localized GFP reporters to generate traceable, mosaic SynCAM 
expression patterns.  This allowed me to separate cell autonomous and non-autonomous effects 
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and differentiate pre- and postsynaptic functions of SynCAM1-3.  Taken together, the tools that I 
present represent major advancements in molecular biology techniques and should prove useful 
for future studies necessitating genetic loss-of-function.    
 Furthermore, use of these tools in Chapter III elucidated previously unknown functions of 
SynCAMs in synapse formation.  Comparisons solidified that SynCAM1-3 function redundantly 
to regulate excitatory synapse density and size.  Importantly, these tools allowed for the 
conclusion that SynCAMs function through postsynaptic mechanisms.  Additionally, I 
determined that SynCAM effects are limited to a subset of dendrites, opening the door for further 
experimentation on distinct dendrite-specific functions. It will be interesting to see how these 
tools are expanded upon, especially the application of overexpression methods in combination 
with the knockdown tools developed here, and how these add to our understanding of SynCAM 
function.  Overall, these results represent a foundational framework for the development of a 
cohesive SynCAM functional model.   
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APPENDIX 
SUPPLEMENTARY FIGURES FOR CHAPTER II 
 
Supplementary Figure S1 (next page).  Changes to knockdown efficiency of hairpins expressed 
in modified SIBR backbones as monitored by quantitative western blotting.      (A)  Near-infrared 
western blot images and raw fluorescence values (A.U.) and (B) calculated knockdown efficiency 
of HA-reporters for indicated amiRNA hairpin sequences expressed from wtSIBR or modified 
backbones following co-transfection in COS7 cells. HA-Reporter levels were first normalized to 
actin loading control levels and knockdown efficiency was calculated versus the control (empty) 
condition. If more than one technical replicate was performed for a trial a representative replicate 
for that sample is shown in (A) and average knockdown efficiencies from 2-3 technical replicates 
is reported in bold font in (B).  For gels that were not loaded in the order presented, composite 
blots were made from the same scan and intensity. 
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Supplementary Figure S2. Quantitative near-infrared western blotting reliably measures subtle 
changes in protein levels.  (A)  Near-infrared western blot images and raw fluorescence values 
(A.U.) and (B) calculated relative HA-reporter levels (A.U.) for three independent COS7 cell 
lysate samples following transfection with HA-Reporter. Increasing 10% amounts of lysates were 
loaded on gels in quadruplicate or triplicate as indicated and subjected to quantitative western 
blotting.  Raw HA-reporter intensities were first set relative to the mean value for the 10 µl 
loading condition, which was then set arbitrarily at a relative HA intensity of 10 in order to 
illustrate the linearity of measured values. Values presented in (B) represent means of the 
quadruplicate or triplicate loadings.  *p<0.05, **p<0.01, ***p<0.001, ANOVA with Tukey’s post 
hoc pairwise comparisons for HA-Nlgn1 samples, Student’s two-tailed t-test for HA-Cadm1 
samples. Error bars represent S.E.M.   
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